MASS GENERAL BRIGHAM INCORPORATED: Form 990, tax year 2013
View the entire original 990 at ProPublica ↗
- Organization
- MASS GENERAL BRIGHAM INCORPORATED (EIN 04-2103591)
- Tax period
- 2013-10-01 to 2014-09-30
- Filed
- 2015-08-17
- IRS object ID
- 201532299349300918
- Schema version
- 2013v4.0
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule C
- Schedule D
- Schedule F
- Schedule G
- Schedule H
- Schedule I
- Schedule J
- Schedule K
- Schedule L
- Schedule O
- Schedule R
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2015-08-17T07:53:09-05:00 | ReturnTs |
| Tax Period End | 2014-09-30 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | PricewaterhouseCoopers LLP | BusinessNameLine1 |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 125 High Street | AddressLine1 |
| City | Boston | City |
| State | MA | State |
| ZIP Code | 02110 | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2013-10-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 042103591 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | MASSACHUSETTS EYE & EAR INFIRMARY | BusinessNameLine1 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| In Care Of | % CAROLANN WILLIAMS | InCareOfNm |
| Business Name Control | MASS | BusinessNameControlTxt |
| Phone | 6175733942 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 243 CHARLES STREET | AddressLine1 |
| Address Line2 | Suite | AddressLine2 |
| City | BOSTON | City |
| State | MA | State |
| ZIP Code | 02114 | ZIPCode |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | CAROLANN WILLIAMS | PersonNm |
| Person Title | CFO & VP FIN AND ADMIN | PersonTitleTxt |
| Phone | 6175733012 | PhoneNum |
| Signature | 2015-08-04 | SignatureDt |
| Discuss With Paid Preparer | Yes (true) | DiscussWithPaidPreparerInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | ERIN COUTURE | PreparerPersonNm |
| PTIN | P01390592 | PTIN |
| Phone | 6175733012 | PhoneNum |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2013 | TaxYr |
| Build TS | 2016-02-25 16:41:14Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | CAROLANN WILLIAMS | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 243 CHARLES STREET | AddressLine1 |
| City | BOSTON | City |
| State | MA | State |
| ZIP Code | 02114 | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $228,069,599 | GrossReceiptsAmt |
| Group Return For Affiliates | false | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | WWW.MASSEYEANDEAR.ORG | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 1827 | FormationYr |
| Legal Domicile State | MA | LegalDomicileStateCd |
| Activity Or Mission | SEE SCHEDULE O. | ActivityOrMissionDesc |
| Voting Members Governing Body | 21 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 19 | VotingMembersIndependentCnt |
| Total Employee | 1993 | TotalEmployeeCnt |
| Total Volunteers | 257 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| PY Contributions Grants | $39,413,484 | PYContributionsGrantsAmt |
| CY Contributions Grants | $41,532,901 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $164,905,375 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $170,833,796 | CYProgramServiceRevenueAmt |
| PY Investment Income | $1,067,489 | PYInvestmentIncomeAmt |
| CY Investment Income | $1,702,348 | CYInvestmentIncomeAmt |
| PY Other Revenue | $16,279,280 | PYOtherRevenueAmt |
| CY Other Revenue | $14,000,554 | CYOtherRevenueAmt |
| PY Total Revenue | $221,665,628 | PYTotalRevenueAmt |
| CY Total Revenue | $228,069,599 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $16,717,561 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $17,798,238 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $106,973,420 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $103,616,750 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $278,479 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $190,046 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $2,145,325 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $98,774,910 | PYOtherExpensesAmt |
| CY Other Expenses | $106,456,236 | CYOtherExpensesAmt |
| PY Total Expenses | $222,744,370 | PYTotalExpensesAmt |
| CY Total Expenses | $228,061,270 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | -$1,078,742 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $8,329 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $224,049,415 | TotalAssetsBOYAmt |
| Total Assets EOY | $209,199,752 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $187,529,630 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $180,665,195 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $36,519,785 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $28,534,557 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | SEE SCHEDULE O. | MissionDesc |
| Significant New Program Srvc | false | SignificantNewProgramSrvcInd |
| Significant Change | false | SignificantChangeInd |
| Expense | $42,489,205 | ExpenseAmt |
| Grant | $5,213,307 | GrantAmt |
| Revenue | $170,833,796 | RevenueAmt |
| Desc | SEE SCHEDULE O | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $3,958,309 | ExpenseAmt |
| Grant | $3,693 | GrantAmt |
| Desc | SEE SCHEDULE O | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $120,820,443 | ExpenseAmt |
| Grant | $12,581,238 | GrantAmt |
| Desc | SEE SCHEDULE O | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Expenses | $167,267,957 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (true) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (true) | ScheduleBRequiredInd |
| Political Campaign Acty | false | PoliticalCampaignActyInd |
| Lobbying Activities | Yes (true) | LobbyingActivitiesInd |
| Subject To Proxy Tax | false | SubjectToProxyTaxInd |
| Donor Advised Fund | false | DonorAdvisedFundInd |
| Conservation Easements | false | ConservationEasementsInd |
| Collections Of Art | Yes (true) | CollectionsOfArtInd |
| Credit Counseling | false | CreditCounselingInd |
| Temp Or Permanent Endowments | Yes (true) | TempOrPermanentEndowmentsInd |
| Report Land Building Equipment | Yes (true) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | false | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | false | ReportProgramRelatedInvstInd |
| Report Other Assets | Yes (true) | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (true) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (true) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | false | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | Yes (true) | ConsolidatedAuditFinclStmtInd |
| School Operating | false | SchoolOperatingInd |
| Foreign Office | false | ForeignOfficeInd |
| Foreign Activities | Yes (true) | ForeignActivitiesInd |
| More Than5000 K To Org | Yes (true) | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | false | MoreThan5000KToIndividualsInd |
| Professional Fundraising | Yes (true) | ProfessionalFundraisingInd |
| Fundraising Activities | false | FundraisingActivitiesInd |
| Gaming Activities | false | GamingActivitiesInd |
| Operate Hospital | Yes (true) | OperateHospitalInd |
| Audited Financial Stmt Att | Yes (true) | AuditedFinancialStmtAttInd |
| Grants To Organizations | Yes (true) | GrantsToOrganizationsInd |
| Grants To Individuals | false | GrantsToIndividualsInd |
| Schedule J Required | Yes (true) | ScheduleJRequiredInd |
| Tax Exempt Bonds | Yes (true) | TaxExemptBondsInd |
| Invest Tax Exempt Bonds | false | InvestTaxExemptBondsInd |
| Escrow Account | false | EscrowAccountInd |
| On Behalf Of Issuer | false | OnBehalfOfIssuerInd |
| Engaged In Excess Benefit Trans | false | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | false | PYExcessBenefitTransInd |
| Loan Outstanding | Yes (true) | LoanOutstandingInd |
| Grant To Related Person | false | GrantToRelatedPersonInd |
| Business Rln With Org Mem | Yes (true) | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | false | BusinessRlnWithFamMemInd |
| Business Rln With Officer Ent | false | BusinessRlnWithOfficerEntInd |
| Deductible Non Cash Contri | false | DeductibleNonCashContriInd |
| Deductible Art Contribution | false | DeductibleArtContributionInd |
| Terminate Operations | false | TerminateOperationsInd |
| Partial Liquidation | false | PartialLiquidationInd |
| Disregarded Entity | false | DisregardedEntityInd |
| Related Entity | Yes (true) | RelatedEntityInd |
| Related Organization Ctrl Ent | Yes (true) | RelatedOrganizationCtrlEntInd |
| Transaction With Control Ent | Yes (true) | TransactionWithControlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | Yes (true) | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | false | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (true) | ScheduleORequiredInd |
| IRP Document | 144 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (true) | BackupWthldComplianceInd |
| Employee | 1993 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (true) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | false | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | false | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | false | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | false | TaxablePartyNotificationInd |
| Nondeductible Contributions | false | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | false | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | false | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | false | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | false | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | false | IndoorTanningServicesInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 21 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 19 | IndependentVotingMemberCnt |
| Family Or Business Rln | false | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | false | DelegationOfMgmtDutiesInd |
| Change To Org Documents | false | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | false | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | false | MembersOrStockholdersInd |
| Election Of Board Members | Yes (true) | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | Yes (true) | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (true) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (true) | MinutesOfCommitteesInd |
| Officer Mailing Address | false | OfficerMailingAddressInd |
| Local Chapters | false | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (true) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (true) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (true) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (true) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (true) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (true) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (true) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (true) | CompensationProcessOtherInd |
| Investment In Joint Venture | false | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | MA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NY | StatesWhereCopyOfReturnIsFldCd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | CAROLANN WILLIAMS | PersonNm |
| Phone | 6175733012 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 243 CHARLES STREET | AddressLine1 |
| City | BOSTON | City |
| State | MA | State |
| ZIP Code | 02114 | ZIPCode |
Form990 Part VII Section A Form990PartVIISectionAGrp (40 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | Key EmployeeKeyEmployeeInd | Highest Compensated EmployeeHighestCompensatedEmployeeInd |
|---|---|---|---|---|---|---|---|---|---|
| JOHN R FERNANDEZ | |||||||||
| PRESIDENT | 37.0 | 23.0 | Yes (X) | Yes (X) | $793,469 | $0 | $207,663 | ||
| WYCLIFFE GROUSBECK | |||||||||
| CHAIR | 3.0 | 7.0 | Yes (X) | Yes (X) | |||||
| JONATHAN UHRIG | |||||||||
| TREASURER | 3.0 | 7.0 | Yes (X) | Yes (X) | |||||
| LILY H BENTAS | |||||||||
| SECRETARY (until 4/29/14) | 3.0 | 7.0 | Yes (X) | Yes (X) | |||||
| RICHARD H ALDRICH | |||||||||
| DIRECTOR | 2.0 | 2.0 | Yes (X) | ||||||
| DEWALT PETE ANKENY | |||||||||
| DIRECTOR | 2.0 | 6.0 | Yes (X) | ||||||
| JAMES CARLISLE | |||||||||
| DIRECTOR | 2.0 | 2.0 | Yes (X) | ||||||
| CHARLES DE GUNZBURG | |||||||||
| DIRECTOR | 2.0 | 6.0 | Yes (X) | ||||||
| SAMUEL FLEMING | |||||||||
| DIRECTOR | 2.0 | 2.0 | Yes (X) | ||||||
| HARVEY FREISHTAT | |||||||||
| DIRECTOR | 2.0 | 2.0 | Yes (X) | ||||||
| LYLE HOWLAND | |||||||||
| DIRECTOR | 2.0 | 2.0 | Yes (X) | ||||||
| DIANE E KANEB | |||||||||
| DIRECTOR | 2.0 | 2.0 | Yes (X) | ||||||
| JONATHAN KUTCHINS | |||||||||
| DIRECTOR | 2.0 | 4.0 | Yes (X) | ||||||
| VICTORIA MCCULLOUGH | |||||||||
| DIRECTOR | 2.0 | 6.0 | Yes (X) | ||||||
| JOAN W MILLER MD | |||||||||
| DIRECTOR | 27.0 | 33.0 | Yes (X) | $0 | $765,352 | $58,725 | |||
| JOSEPH B NADOL JR MD | |||||||||
| DIRECTOR (until 2/28/2014) | 29.0 | 31.0 | Yes (X) | $0 | $773,544 | $58,846 | |||
| ANNETTE NOVA | |||||||||
| DIRECTOR | 2.0 | 6.0 | Yes (X) | $0 | $0 | ||||
| WILLIAM ROMAN | |||||||||
| DIRECTOR | 2.0 | 2.0 | Yes (X) | ||||||
| FREDERICK THORNE | |||||||||
| DIRECTOR | 2.0 | 2.0 | Yes (X) | ||||||
| KATHRYN VECELLIO | |||||||||
| DIRECTOR | 2.0 | 6.0 | Yes (X) | ||||||
| EUGENE HILL | |||||||||
| Director | 2.0 | 2.0 | Yes (X) | ||||||
| D BRADLEY WELLING MD | |||||||||
| Director (effective 3/1/14) | 29.0 | 31.0 | Yes (X) | ||||||
| ROBERT ATCHINSON | |||||||||
| DIRECTOR (EFFECTIVE 3/4/14) | 2.0 | 2.0 | Yes (X) | ||||||
| MAUREEN KELLEY | |||||||||
| ASST SECRETARY | 53.0 | 7.0 | Yes (X) | $184,820 | $0 | $30,228 | |||
| CAROLANN WILLIAMS | |||||||||
| CFO & VP FINANCE AND ADMIN | 49.0 | 11.0 | Yes (X) | $366,768 | $0 | $11,715 | |||
| MARTHA PYLE FARRELL | |||||||||
| Assistant Secretary | 3.0 | 57.0 | Yes (X) | $61,106 | $0 | $6,629 | |||
| BARBARA J SCULLY | |||||||||
| DIRECTOR PROF REV CYCLE | 30.0 | 30.0 | $180,968 | $0 | $36,321 | Yes (X) | |||
| EILEEN O LOWELL | |||||||||
| CNO & VP PAT CARE SVS | 60.0 | $255,012 | $0 | $37,914 | Yes (X) | ||||
| ALAN K LONG | |||||||||
| VP RESEARCH ADMINISTRATION | 30.0 | 30.0 | $227,841 | $0 | $9,626 | Yes (X) | |||
| KENNETH HOLMES | |||||||||
| CFO MEEA | 30.0 | 30.0 | $314,767 | $38,884 | Yes (X) | ||||
| JEAN E MACQUIDDY | |||||||||
| VP OTOLARYNGOLOGY(UNTIL3/1/14) | 30.0 | 30.0 | $247,719 | $0 | $35,286 | Yes (X) | |||
| JEFFREY J PIKE | |||||||||
| CHIEF OPERATING OFFICER | 60.0 | $328,425 | $0 | $21,475 | Yes (X) | ||||
| JAVIER BALLOFFET | |||||||||
| VP OPHTHALMOLOGY(until 5/2/14) | 20.0 | 40.0 | $255,563 | $0 | $38,826 | Yes (X) | |||
| RALPH T PELOSI | |||||||||
| DIRECTOR FACILITIES PLANNING | 60.0 | $178,592 | $0 | $9,174 | Yes (X) | ||||
| MICHAEL RICCI | |||||||||
| CHIEF INFORMATION OFFICER | 60.0 | $226,998 | $31,624 | Yes (X) | |||||
| SUSAN WILLIAMS | |||||||||
| ASST SEC/GC (UNTIL 8/7/13) | 49.0 | 11.0 | $229,297 | $0 | $8,955 | Yes (X) | |||
| CHRISTINE REGAN | |||||||||
| VP HUMAN RSRCS (until 8/9/13) | 60.0 | $268,295 | $0 | $10,652 | Yes (X) | ||||
| JENNIFER STREET | |||||||||
| VP COMMUNICATIONS & PLANNING | 60.0 | $323,773 | $0 | $35,918 | Yes (X) | ||||
| MELISSA M PAUL | |||||||||
| CHIEF DEVELOPMENT OFFICER | 60.0 | $233,645 | $0 | $38,424 | Yes (X) | ||||
| PHILLIP C JOHNSON | |||||||||
| DIR FINANCIAL OPERATIONS | 60.0 | $188,403 | $0 | $43,366 | Yes (X) | ||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $4,865,461 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $1,538,896 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $770,251 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 194 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | false | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (true) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | false | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (5 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1 | CityContractorAddress/USAddress/City | StateContractorAddress/USAddress/State | ZIP CodeContractorAddress/USAddress/ZIPCode | ServicesServicesDesc | CompensationCompensationAmt |
|---|---|---|---|---|---|
| CG ASSOCIATES | |||||
| 7 CHUCK DRIVE UNIT C | DRACUT | MA | 01826 | CONSTRUCTION | $641,053 |
| FISH AND RICHARDSON PC | |||||
| PO BOX 3295 | BOSTON | MA | 02241 | LEGAL SERVICES | $469,200 |
| LFREP SERVICES LLC | |||||
| 260 FRANKLIN STREET | BOSTON | MA | 02110 | DEVELOPMENT SERVICES | $447,631 |
| PRICEWATERHOUSECOOPERS LLP | |||||
| PO BOX 7247-8001 | PHILADELPHIA | PA | 19103 | AUDIT SERVICES | $400,129 |
| GOODWIN PROCTER | |||||
| EXCHANGE PLACE 53 STATE STREET | BOSTON | MA | 02109 | LEGAL SERVICES | $228,885 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 14 | CntrctRcvdGreaterThan100KCnt |
| Related Organizations | $14,230,399 | RelatedOrganizationsAmt |
| Government Grants | $16,028,150 | GovernmentGrantsAmt |
| All Other Contributions | $11,274,352 | AllOtherContributionsAmt |
| Total Contributions | $41,532,901 | TotalContributionsAmt |
Program Service Revenue ProgramServiceRevenueGrp (5 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt |
|---|---|---|---|
| INPATIENT AND OUTPATIENT | 900099 | $152,017,245 | $152,017,245 |
| RESEARCH INDIRECT REVENUE | 900099 | $7,012,603 | $7,012,603 |
| HEARING AID CENTERS | 900099 | $4,194,583 | $4,194,583 |
| CAFETERIA/FOOD SERVICE | 900099 | $1,883,633 | $1,883,633 |
| MISCELLANEOUS REVENUE | 722210 | $5,725,732 | $5,725,732 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | $170,833,796 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $57,039 | TotalRevenueColumnAmt |
| Exclusion | $57,039 | ExclusionAmt |
Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Royalties Revenue RoyaltiesRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $14,000,554 | TotalRevenueColumnAmt |
| Exclusion | $14,000,554 | ExclusionAmt |
Rental Income Or Loss RentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $0 | RealAmt |
| Personal | $0 | PersonalAmt |
Net Rental Income Or Loss NetRentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $1,645,309 | SecuritiesAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $1,645,309 | SecuritiesAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $1,645,309 | TotalRevenueColumnAmt |
| Exclusion | $1,645,309 | ExclusionAmt |
Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Net Income From Gaming NetIncomeFromGamingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Net Income Or Loss NetIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | $0 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $228,069,599 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $170,833,796 | RelatedOrExemptFuncIncomeAmt |
| Exclusion | $15,702,902 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part IX | Yes (X) | InfoInScheduleOPartIXInd |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $17,733,499 | TotalAmt |
| Program Services | $17,733,499 | ProgramServicesAmt |
Grants To Domestic Individuals GrantsToDomesticIndividualsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $64,739 | TotalAmt |
| Program Services | $64,739 | ProgramServicesAmt |
Benefits To Members BenefitsToMembersGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,848,724 | TotalAmt |
| Program Services | $1,073,594 | ProgramServicesAmt |
| Management And General | $1,560,489 | ManagementAndGeneralAmt |
| Fundraising | $214,641 | FundraisingAmt |
Comp Disqual Persons CompDisqualPersonsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $79,913,592 | TotalAmt |
| Program Services | $61,302,167 | ProgramServicesAmt |
| Management And General | $17,559,460 | ManagementAndGeneralAmt |
| Fundraising | $1,051,965 | FundraisingAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,526,099 | TotalAmt |
| Program Services | $1,166,568 | ProgramServicesAmt |
| Management And General | $331,906 | ManagementAndGeneralAmt |
| Fundraising | $27,625 | FundraisingAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $12,495,092 | TotalAmt |
| Program Services | $9,551,393 | ProgramServicesAmt |
| Management And General | $2,717,516 | ManagementAndGeneralAmt |
| Fundraising | $226,183 | FundraisingAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $6,833,243 | TotalAmt |
| Program Services | $5,223,410 | ProgramServicesAmt |
| Management And General | $1,486,139 | ManagementAndGeneralAmt |
| Fundraising | $123,694 | FundraisingAmt |
Fees For Services Management FeesForServicesManagementGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $944,895 | TotalAmt |
| Program Services | $755,961 | ProgramServicesAmt |
| Management And General | $188,934 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $496,758 | TotalAmt |
| Program Services | $146,868 | ProgramServicesAmt |
| Management And General | $349,890 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Fees For Services Lobbying FeesForServicesLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $126,000 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
| Management And General | $126,000 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Fees For Services Prof Fundraising FeesForServicesProfFundraising
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $190,046 | TotalAmt |
| Fundraising | $190,046 | FundraisingAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,407,794 | TotalAmt |
| Program Services | $2,884,119 | ProgramServicesAmt |
| Management And General | $523,675 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,002,119 | TotalAmt |
| Program Services | $9,973 | ProgramServicesAmt |
| Management And General | $992,146 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,061,524 | TotalAmt |
| Program Services | $1,160,403 | ProgramServicesAmt |
| Management And General | $794,588 | ManagementAndGeneralAmt |
| Fundraising | $106,533 | FundraisingAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,849,549 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
| Management And General | $2,849,549 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Royalties RoyaltiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $12,120,735 | TotalAmt |
| Program Services | $892,910 | ProgramServicesAmt |
| Management And General | $11,227,825 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,196,464 | TotalAmt |
| Program Services | $805,778 | ProgramServicesAmt |
| Management And General | $358,604 | ManagementAndGeneralAmt |
| Fundraising | $32,082 | FundraisingAmt |
Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
Interest InterestGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,470,354 | TotalAmt |
| Program Services | $1,623,306 | ProgramServicesAmt |
| Management And General | $847,048 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Payments To Affiliates PaymentsToAffiliatesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
| Program Services | $0 | ProgramServicesAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $18,751,456 | TotalAmt |
| Program Services | $12,321,860 | ProgramServicesAmt |
| Management And General | $6,429,596 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,244,992 | TotalAmt |
| Program Services | $68,514 | ProgramServicesAmt |
| Management And General | $1,176,478 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt | FundraisingFundraisingAmt |
|---|---|---|---|---|
| MEDICAL SUPPLIES | $34,457,027 | $34,330,104 | $126,923 | $0 |
| PHYSICIANS ADMINISTRATION | $5,422,250 | $5,328,970 | $93,280 | $0 |
| MISCELLANEOUS | $9,613,421 | $6,177,044 | $3,280,847 | $155,530 |
| ALL OTHER EXPENSES | $10,290,898 | $4,646,777 | $5,627,095 | $17,026 |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $228,061,270 | TotalAmt |
| Program Services | $167,267,957 | ProgramServicesAmt |
| Management And General | $58,647,988 | ManagementAndGeneralAmt |
| Fundraising | $2,145,325 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,374,003 | BOYAmt |
| EOY | $566,415 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $360,000 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $21,380,084 | BOYAmt |
| EOY | $22,892,699 | EOYAmt |
Receivables From Officers Etc ReceivablesFromOfficersEtcGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $10,000 | BOYAmt |
| EOY | $10,000 | EOYAmt |
Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Inventories For Sale Or Use InventoriesForSaleOrUseGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,302,498 | BOYAmt |
| EOY | $3,028,866 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,078,975 | BOYAmt |
| EOY | $4,195,936 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $391,123,990 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $255,776,662 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $138,441,661 | BOYAmt |
| EOY | $135,347,328 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Investments Other Securities InvestmentsOtherSecuritiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Investments Program Related InvestmentsProgramRelatedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Intangible Assets IntangibleAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $56,462,194 | BOYAmt |
| EOY | $42,798,508 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $224,049,415 | BOYAmt |
| EOY | $209,199,752 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $70,433,190 | BOYAmt |
| EOY | $77,351,461 | EOYAmt |
Grants Payable GrantsPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $25,513,725 | BOYAmt |
| EOY | $14,295,172 | EOYAmt |
Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $83,647,571 | BOYAmt |
| EOY | $80,998,192 | EOYAmt |
Escrow Account Liability EscrowAccountLiabilityGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Loans From Officers Directors LoansFromOfficersDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $7,935,144 | BOYAmt |
| EOY | $8,020,370 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $187,529,630 | BOYAmt |
| EOY | $180,665,195 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows SFAS117 | Yes (X) | OrganizationFollowsSFAS117Ind |
Unrestricted Net Assets UnrestrictedNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $36,519,785 | BOYAmt |
| EOY | $28,174,557 | EOYAmt |
Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $360,000 | EOYAmt |
Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $36,519,785 | BOYAmt |
| EOY | $28,534,557 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $224,049,415 | BOYAmt |
| EOY | $209,199,752 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part XI | Yes (X) | InfoInScheduleOPartXIInd |
| Reconcilation Revenue Expnss | $8,329 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | -$36,784 | NetUnrlzdGainsLossesInvstAmt |
| Other Changes In Net Assets | -$7,956,773 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | false | AccountantCompileOrReviewInd |
| FS Audited | Yes (true) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Consolidated Basis Fincl Stmt | Yes (X) | ConsolidatedBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (true) | AuditCommitteeInd |
| Federal Grant Audit Required | Yes (true) | FederalGrantAuditRequiredInd |
| Federal Grant Audit Performed | Yes (true) | FederalGrantAuditPerformedInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Hospital | Yes (X) | HospitalInd |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $39,220,406 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $37,417,260 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $33,572,100 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $39,413,484 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $41,532,901 | CurrentTaxYearAmt |
| Total | $191,156,151 | TotalAmt |
Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $39,220,406 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $37,417,260 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $33,572,100 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $39,413,484 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $41,532,901 | CurrentTaxYearAmt |
| Total | $191,156,151 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $0 | SubstantialContributorsTotAmt |
| Public Support Total170 | $191,156,151 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $13,360,234 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $11,313,782 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $15,165,483 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $16,370,797 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $14,057,593 | CurrentTaxYearAmt |
| Total | $70,267,889 | TotalAmt |
Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Other Income170 OtherIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $733,262 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $1,457,363 | CurrentTaxYearMinus3YearsAmt |
| Total | $2,190,625 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $263,614,665 | TotalSupportAmt |
| Gross Receipts Rltd Activities | $802,149,364 | GrossReceiptsRltdActivitiesAmt |
| Public Support CY170 | 0.72513 | PublicSupportCY170Pct |
| Public Support PY170 | 0.00000 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule C IRS990ScheduleC
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Grassroots Lobbying | TotalGrassrootsLobbyingGrp | |
| Total Direct Lobbying | TotalDirectLobbyingGrp | |
| Total Lobbying Expend | TotalLobbyingExpendGrp | |
| Other Exempt Purpose Expend | OtherExemptPurposeExpendGrp | |
| Total Exempt Purpose Expend | TotalExemptPurposeExpendGrp | |
| Lobbying Nontaxable Amount | LobbyingNontaxableAmountGrp | |
| Grassroots Nontaxable | GrassrootsNontaxableGrp | |
| Tot Lbbyng Grassroot Mns Non Tx | TotLbbyngGrassrootMnsNonTxGrp | |
| Tot Lbby Expend Mns Lbbyng Non Tx | TotLbbyExpendMnsLbbyngNonTxGrp | |
| Volunteers | false | VolunteersInd |
| Paid Staff Or Management | Yes (true) | PaidStaffOrManagementInd |
| Media Advertisements | false | MediaAdvertisementsInd |
| Mailings Members | Yes (true) | MailingsMembersInd |
| Publications Or Broadcast | false | PublicationsOrBroadcastInd |
| Grants Other Organizations | false | GrantsOtherOrganizationsInd |
| Direct Contact Legislators | Yes (true) | DirectContactLegislatorsInd |
| Direct Contact Legislators | $126,000 | DirectContactLegislatorsAmt |
| Rallies Demonstrations | false | RalliesDemonstrationsInd |
| Other Activities | false | OtherActivitiesInd |
| Total Lobbying Expenditures | $126,000 | TotalLobbyingExpendituresAmt |
| Not Described Section501c3 | false | NotDescribedSection501c3Ind |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | SCHEDULE C, PART II-B, LINE 1(I): | FormAndLineReferenceDesc |
| Explanation | During Fiscal Year 2014, Mass. Eye and Ear paid consulting fees for assistance with advocacy for a state bill that authorized the hospital to negotiate with the state of Massachusetts for a land lease. This bill passed and was signed in July/August of 2014. Additionally, these paid consultants assisted with developing state and federal legislative strategies, and served as a liaison to government agencies as necessary and monitor and report on government programs relative to healthcare financing, including state appropriations and grants. Mass. Eye and Ear is a member of certain trade associations they may lobby on its behalf. | ExplanationTxt |
Schedule D IRS990ScheduleD
| Field | Value | IRS element (for citing) |
|---|---|---|
| Art Public Exhibition Amounts | ArtPublicExhibitionAmountsGrp | |
| Held Works Art | HeldWorksArtGrp | |
| Collection Used Pub Exhibition | Yes (X) | CollectionUsedPubExhibitionInd |
| Coll Used Scholarly Rsrch | Yes (X) | CollUsedScholarlyRsrchInd |
| Collection Used Preservation | Yes (X) | CollectionUsedPreservationInd |
| Coll Used Loan Or Exch Prog | Yes (X) | CollUsedLoanOrExchProgInd |
| Solicited Assets Sale | false | SolicitedAssetsSaleInd |
CY Endwmt Fund CYEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $87,204,664 | BeginningYearBalanceAmt |
| Contributions | $746,394 | ContributionsAmt |
| Investment Earnings Or Losses | $5,114,694 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $12,790,648 | OtherExpendituresAmt |
| Administrative Expenses | $1,763,453 | AdministrativeExpensesAmt |
| End Year Balance | $78,511,651 | EndYearBalanceAmt |
CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $89,724,541 | BeginningYearBalanceAmt |
| Contributions | $2,692,680 | ContributionsAmt |
| Investment Earnings Or Losses | $3,521,682 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $7,238,556 | OtherExpendituresAmt |
| Administrative Expenses | $1,495,683 | AdministrativeExpensesAmt |
| End Year Balance | $87,204,664 | EndYearBalanceAmt |
CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $86,399,272 | BeginningYearBalanceAmt |
| Contributions | $1,269,332 | ContributionsAmt |
| Investment Earnings Or Losses | $6,139,492 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $2,803,513 | OtherExpendituresAmt |
| Administrative Expenses | $1,280,042 | AdministrativeExpensesAmt |
| End Year Balance | $89,724,541 | EndYearBalanceAmt |
CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $60,472,244 | BeginningYearBalanceAmt |
| Contributions | $29,640,100 | ContributionsAmt |
| Investment Earnings Or Losses | $1,622,561 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $4,005,052 | OtherExpendituresAmt |
| Administrative Expenses | $1,330,581 | AdministrativeExpensesAmt |
| End Year Balance | $86,399,272 | EndYearBalanceAmt |
CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $60,355,993 | BeginningYearBalanceAmt |
| Contributions | $736,023 | ContributionsAmt |
| Investment Earnings Or Losses | $4,138,384 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $3,579,845 | OtherExpendituresAmt |
| Administrative Expenses | $1,178,311 | AdministrativeExpensesAmt |
| End Year Balance | $60,472,244 | EndYearBalanceAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Board Designated Balance EOY | 0.06240 | BoardDesignatedBalanceEOYPct |
| Prmnnt Endowment Balance EOY | 0.66520 | PrmnntEndowmentBalanceEOYPct |
| Term Endowment Balance EOY | 0.27240 | TermEndowmentBalanceEOYPct |
| Endowments Held Unrelated Org | false | EndowmentsHeldUnrelatedOrgInd |
| Endowments Held Related Org | Yes (true) | EndowmentsHeldRelatedOrgInd |
| Related Org List Sch R | Yes (true) | RelatedOrgListSchRInd |
Land LandGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $535,324 | OtherCostOrOtherBasisAmt |
| Book Value | $535,324 | BookValueAmt |
Buildings BuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $178,463,262 | OtherCostOrOtherBasisAmt |
| Depreciation | $113,430,398 | DepreciationAmt |
| Book Value | $65,032,864 | BookValueAmt |
Leasehold Improvements LeaseholdImprovementsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $15,196,931 | OtherCostOrOtherBasisAmt |
| Depreciation | $2,064,793 | DepreciationAmt |
| Book Value | $13,132,138 | BookValueAmt |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $184,024,402 | OtherCostOrOtherBasisAmt |
| Depreciation | $140,236,698 | DepreciationAmt |
| Book Value | $43,787,704 | BookValueAmt |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $12,904,071 | OtherCostOrOtherBasisAmt |
| Depreciation | $44,773 | DepreciationAmt |
| Book Value | $12,859,298 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $135,347,328 | TotalBookValueLandBuildingsAmt |
Other Assets Org OtherAssetsOrgGrp (10 entries)
| DescDesc | Book ValueBookValueAmt |
|---|---|
| DUE FROM AFFILIATES | $23,365,037 |
| FUNDS HELD FOR RESEARCH | $476,269 |
| CONSTRUCTION FUND | $3,671,296 |
| DEBT SERVICE FUND | $99,436 |
| SPECIAL CASH & CAPITAL RESERVE | $3,812,308 |
| DEBT SERVICE RESERVES FUND | $6,443,827 |
| DEFERRED FINANCING COSTS | $1,452,248 |
| TAX DEFERRED PLAN | $1,381,623 |
| CRICO | $2,089,293 |
| QLT | $7,171 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Other Assets | $42,798,508 | TotalBookValueOtherAssetsAmt |
| Federal Income Tax Liability | $0 | FederalIncomeTaxLiabilityAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp (4 entries)
| DescDesc | AmtAmt |
|---|---|
| DUE TO AFFILIATES | $117,211 |
| ESTIMATE THIRD PARTY SETTLEMEN | $3,912,860 |
| PROFESSIONAL LIABILITY RESERVE | $2,608,676 |
| TAX DEFERRED LIABILITY | $1,381,623 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $8,020,370 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| SCHEDULE D, PART III, LINE 4: | THE RARE BOOKS COLLECTION CONSISTS MAINLY OF SEVERAL HUNDRED BOOKS IN THE MEEI specialties of ophthalmology and otolaryngology as well as a few on the medical history of Boston and Massachusetts. The majority were donated originally by Moses Lurie, MD and Mrs. Lucien Howe (wife of Lucien Howe, MD). A few were donated by other physicians through the years. Endowment funds set up between Mrs. Howe and Dr. Lurie were designated for the occasional purchase of rare books to supplement the original donations. The rare books are available to the scientific, medical and academic community for purposes of research and education. SCHEDULE D, PART V, LINE 4: THE ENDOWMENT FUNCTIONS TO SUPPORT THE MISSION OF THE MASSACHUSETTS EYE AND EAR INFIRMARY TO PROVIDE SUPERIOR PATIENT CARE AND RESEARCH. THE INCOME FROM THE ENDOWMENT FUNDS ARE SUBJECT TO DONOR-IMPOSED STIPULATIONS USUALLY FOR RESEARCH, EDUCATION AND PATIENT CARE. |
| SCHEDULE D, PART X, LINE 2: | THE MASSACHUSETTS EYE AND EAR INFIRMARY ("INFIRMARY") WAS INCLUDED IN CONSOLIDATED FINANCIAL STATEMENTS WITH ITS AFFILIATED ORGANIZATIONS. THE INCOME TAX FOOTNOTE IS AS FOLLOWS: THE FOUNDATION AND ITS AFFILIATES QUALIFY AS TAX-EXEMPT ORGANIZATIONS UNDER THE INTERNAL REVENUE CODE. THE FOUNDATION, INFIRMARY, ASSOCIATES, SCHEPENS AND EMBANKMENT ARE TAX-EXEMPT UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND CIRCLE IS TAX-EXEMPT UNDER 501(C)(25) OF THE INTERNAL REVENUE CODE. ACCORDINGLY, NO PROVISION FOR INCOME TAXES HAS BEEN MADE IN THE ACCOMPANYING FINANCIAL STATEMENTS. MANAGEMENT HAS EVALUATED ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES AND THERE WAS NO IMPACT TO THE FOUNDATION'S FINANCIAL STATEMENTS FOR THE YEAR ENDED SEPTEMBER 30, 2014. |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (true) | GrantRecordsMaintainedInd |
Account Activities Outside US AccountActivitiesOutsideUSGrp (8 entries)
| RegionRegionTxt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Specific Services ProvidedSpecificServicesProvidedTxt | Region Total ExpendituresRegionTotalExpendituresAmt |
|---|---|---|---|
| Europe (Including Iceland and Greenland) | Program Services | Conference | $108,169 |
| South America | Program Services | Conference | $15,286 |
| North America | Program Services | Conference | $5,827 |
| South Asia | Program Services | Conference | $2,100 |
| Central America and the Caribbean | Program Services | Conference | $5,446 |
| East Asia and the Pacific | Program Services | Conference | $10,536 |
| Central America and the Caribbean | Investments | $24,200 | |
| North America | Program Services | Research | $64,739 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Spent | $236,303 | SubtotalSpentAmt |
| Total Spent | $236,303 | TotalSpentAmt |
Grants To Org Outside US GrantsToOrgOutsideUSGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Region | North America | RegionTxt |
| Purpose Of Grant | RESEARCH | PurposeOfGrantTxt |
| Cash Grant | $64,739 | CashGrantAmt |
| Manner Of Cash Disbursement | Check | MannerOfCashDisbursementTxt |
| Non Cash Assistance | $0 | NonCashAssistanceAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 1 | Total501c3OrgCnt |
| Total Other Org | 1 | TotalOtherOrgCnt |
| Transfer To Foreign Corp | false | TransferToForeignCorpInd |
| Interest In Foreign Trust | false | InterestInForeignTrustInd |
| Foreign Corp Ownership | Yes (true) | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | false | PassiveForeignInvestmestCoInd |
| Foreign Partnership | false | ForeignPartnershipInd |
| Boycott Countries | false | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| SCHEDULE F, PART I, LINE 2: | SUBRECIPIENT MONITORING POLICY AND PROCEDURES Part I Subawards are issued through a consortium agreement between the Massachusetts Eye and Ear Infirmary ("MEEI") and the recipient institution. The agreement specifies the terms of the subaward, and includes a detailed budget and scope of work to be performed by the recipient institution. Awarded funds are encumbered by a purchase order that is assigned to a unique fund number. Payments to recipient institutions made against the purchase order are recorded in the MEEI accounting system so that individual payments and purchase order balances can be monitored. Disbursement of funds for subawards require the written approval of the Principal Investigator("PI"). Frequent progress reports and other forms of communication are required between the PI and the subrecipient institute to ensure that the scope of work is progressing at a satisfactory pace. Research Administration also conducts an annual inventory of institutions to which reserach has been subawarded. A risk assessment matrix is employed, along with a review of the subrecipients most recent A133 audit report, to determine the level of risk regarding the subrecipients ability to comply with federal guidelines. |
| SCHEDULE F, PART I, LINE 3, COLUMN(F) AND PART II, LINE 1: | THE INFIRMARY USES THE ACCRUAL METHOD OF ACCOUNTING AND SEPARATELY IDENTIFIES FOREIGN ACTIVITY ON ITS GENERAL LEDGER. |
Schedule G IRS990ScheduleG
| Field | Value | IRS element (for citing) |
|---|---|---|
| Mail Solicitations | Yes (X) | MailSolicitationsInd |
| Email Solicitations | Yes (X) | EmailSolicitationsInd |
| In Person Solicitations | Yes (X) | InPersonSolicitationsInd |
| Solicitation Of Non Govt Grants | Yes (X) | SolicitationOfNonGovtGrantsInd |
| Solicitation Of Govt Grants | Yes (X) | SolicitationOfGovtGrantsInd |
| Agrmt Prof Fundraising Acty | Yes (true) | AgrmtProfFundraisingActyInd |
Fundraiser Activity Info FundraiserActivityInfoGrp (2 entries)
| ActivityActivityTxt | Fundraiser Control Of FundsFundraiserControlOfFundsInd | Retained By ContractorRetainedByContractorAmt |
|---|---|---|
| VISION PHILANTHROPY GROUP | ||
| CAPITAL CAMPAIGN | false | $115,069 |
| HUNTSINGER JEFFER INC | ||
| ANNUAL FUND | false | $63,000 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Retained By Contractors | $178,069 | TotalRetainedByContractorsAmt |
| Licensed States | ME | LicensedStatesCd |
| Licensed States | MA | LicensedStatesCd |
| Licensed States | NY | LicensedStatesCd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | DURING THE FISCAL YEAR ENDED SEPTEMBER 20, 2014, THE MASSACHUSETTS EYE | FormAndLineReferenceDesc |
| Explanation | AND EAR INFIRMARY ("THE INFIRMARY") CONTRACTED WITH HUNTSINGER & JEFFER, A FUNDRAISING CONSULTING COMPANY, TO ASSIST WITH THE FOUNDATION'S MAILING CAMPAIGN BY DRAFTING LETTERS AND WORKING WITH A MAIL HOUSE TO SEND LETTERS AND EMAILS TO PATIENTS ON THE INFIRMARY'S BEHALF. THE INFIRMARY ALSO CONTRACTED WITH VISION PHILANTHROPY TO ASSIST WITH THE INFIRMARY'S CAPITAL FUNDRAISING CAMPAIGN. | ExplanationTxt |
Schedule H IRS990ScheduleH
| Field | Value | IRS element (for citing) |
|---|---|---|
| Financial Assistance Policy | Yes (true) | FinancialAssistancePolicyInd |
| Written Policy | Yes (true) | WrittenPolicyInd |
| FPG Reference Free Care | Yes (true) | FPGReferenceFreeCareInd |
Free Care Oth Percentage FreeCareOthPercentageGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other | Yes (X) | OtherInd |
| Free Care Other | 400. | FreeCareOtherPct |
| Field | Value | IRS element (for citing) |
|---|---|---|
| FPG Reference Discounted Care | Yes (true) | FPGReferenceDiscountedCareInd |
| Percent400 | Yes (X) | Percent400Ind |
| Free Care Medically Indigent | Yes (true) | FreeCareMedicallyIndigentInd |
| Financial Assistance Budget | Yes (true) | FinancialAssistanceBudgetInd |
| Expenses Exceed Budget | Yes (true) | ExpensesExceedBudgetInd |
| Unable To Provide Care | false | UnableToProvideCareInd |
| Annual Community Bnft Report | Yes (true) | AnnualCommunityBnftReportInd |
| Report Publically Available | Yes (true) | ReportPublicallyAvailableInd |
Financial Assistance At Cost Typ FinancialAssistanceAtCostTyp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $3,373,958 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $3,116,930 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $257,028 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.00110 | TotalExpensePct |
Unreimbursed Medicaid UnreimbursedMedicaidGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $14,881,590 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $11,934,256 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $2,947,334 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.01290 | TotalExpensePct |
Unreimbursed Costs UnreimbursedCostsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $3,362,490 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $2,044,201 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $1,318,289 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.00580 | TotalExpensePct |
Total Financial Assistance Typ TotalFinancialAssistanceTyp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $21,618,038 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $17,095,387 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $4,522,651 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.01980 | TotalExpensePct |
Community Health Services CommunityHealthServicesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $509,635 | TotalCommunityBenefitExpnsAmt |
| Net Community Benefit Expns | $509,635 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.00220 | TotalExpensePct |
Health Professions Education HealthProfessionsEducationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $8,165,803 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $1,460,256 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $6,705,547 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.02940 | TotalExpensePct |
Subsidized Health Services SubsidizedHealthServicesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Activities Or Programs | 2 | ActivitiesOrProgramsCnt |
| Persons Served | 665 | PersonsServedCnt |
| Total Community Benefit Expns | $1,486,292 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $1,186,068 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $300,224 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.00130 | TotalExpensePct |
Research ResearchGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $41,823,183 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $34,809,269 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $7,113,914 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.03120 | TotalExpensePct |
Cash And In Kind Contributions CashAndInKindContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Community Benefit Expns | $34,300 | TotalCommunityBenefitExpnsAmt |
| Net Community Benefit Expns | $34,300 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.00020 | TotalExpensePct |
Total Other Benefits TotalOtherBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Activities Or Programs | 2 | ActivitiesOrProgramsCnt |
| Persons Served | 665 | PersonsServedCnt |
| Total Community Benefit Expns | $52,019,213 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $37,455,593 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $14,663,620 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.06430 | TotalExpensePct |
Total Community Benefits TotalCommunityBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Activities Or Programs | 2 | ActivitiesOrProgramsCnt |
| Persons Served | 665 | PersonsServedCnt |
| Total Community Benefit Expns | $73,637,251 | TotalCommunityBenefitExpnsAmt |
| Direct Offsetting Revenue | $54,550,980 | DirectOffsettingRevenueAmt |
| Net Community Benefit Expns | $19,186,271 | NetCommunityBenefitExpnsAmt |
| Total Expense | 0.08410 | TotalExpensePct |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Bad Debt Expense Reported | Yes (true) | BadDebtExpenseReportedInd |
| Bad Debt Expense | $2,461,675 | BadDebtExpenseAmt |
| Bad Debt Expense Attributable | $9,916 | BadDebtExpenseAttributableAmt |
| Reimbursed By Medicare | $43,526,177 | ReimbursedByMedicareAmt |
| Cost Of Care Reimbursed By Medcr | $46,714,922 | CostOfCareReimbursedByMedcrAmt |
| Medicare Surplus Or Shortfall | -$3,188,745 | MedicareSurplusOrShortfallAmt |
Costing Methodology Used CostingMethodologyUsedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cost Accounting System | Yes (X) | CostAccountingSystemInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Written Debt Collection Policy | Yes (true) | WrittenDebtCollectionPolicyInd |
| Financial Assistance Prvsn | Yes (true) | FinancialAssistancePrvsnInd |
| Hospital Facilities | 1 | HospitalFacilitiesCnt |
Hospital Facilities HospitalFacilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Facility | 1 | FacilityNum |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | MASSACHUSETTS EYE & EAR INFIRMARY | BusinessNameLine1 |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 243 CHARLES STREET | AddressLine1 |
| City | BOSTON | City |
| State | MA | State |
| ZIP Code | 02114 | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Website Address | http://www.masseyeandear.org/ | WebsiteAddressTxt |
| State License | 2167 | StateLicenseNum |
| Licensed Hospital | Yes (X) | LicensedHospitalInd |
| Teaching Hospital | Yes (X) | TeachingHospitalInd |
| Research Facility | Yes (X) | ResearchFacilityInd |
| Emergency Room24 Hrs | Yes (X) | EmergencyRoom24HrsInd |
Hospital Fclty Policies Prctc HospitalFcltyPoliciesPrctcGrp
Hospital Facility Name HospitalFacilityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | MASSACHUSETTS EYE & EAR INFIRMARY | BusinessNameLine1 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| CHNA Conducted | Yes (true) | CHNAConductedInd |
| Community Definition | Yes (X) | CommunityDefinitionInd |
| Community Demographics | Yes (X) | CommunityDemographicsInd |
| Existing Resources | Yes (X) | ExistingResourcesInd |
| How Data Obtained | Yes (X) | HowDataObtainedInd |
| Community Health Needs | Yes (X) | CommunityHealthNeedsInd |
| Other Health Issues | Yes (X) | OtherHealthIssuesInd |
| Community Hlth Needs Id Process | Yes (X) | CommunityHlthNeedsIdProcessInd |
| Consulting Process | Yes (X) | ConsultingProcessInd |
| Information Gaps | Yes (X) | InformationGapsInd |
| CHNA Conducted | 13 | CHNAConductedYr |
| Take Into Account Others Input | Yes (true) | TakeIntoAccountOthersInputInd |
| CHNA Conducted With Other Fclts | false | CHNAConductedWithOtherFcltsInd |
| CHNA Report Widely Available | Yes (true) | CHNAReportWidelyAvailableInd |
| Rpt Available On Own Website | Yes (X) | RptAvailableOnOwnWebsiteInd |
| Own Website URL | WWW.MASSEYEANDEAR.ORG | OwnWebsiteURLTxt |
| Rpt Available Upon Request | Yes (X) | RptAvailableUponRequestInd |
| Adopt Implementation Strategy | Yes (X) | AdoptImplementationStrategyInd |
| Exec Implementation Strategy | Yes (X) | ExecImplementationStrategyInd |
| Develop Community Wide Plan | Yes (X) | DevelopCommunityWidePlanInd |
| Exec Community Wide Plan | Yes (X) | ExecCommunityWidePlanInd |
| Include Operational Plan | Yes (X) | IncludeOperationalPlanInd |
| Adopt Budget | Yes (X) | AdoptBudgetInd |
| Prioritize Health Needs | Yes (X) | PrioritizeHealthNeedsInd |
| Prioritize Services | Yes (X) | PrioritizeServicesInd |
| All Needs Addressed | false | AllNeedsAddressedInd |
| Organization Incur Excise Tax | false | OrganizationIncurExciseTaxInd |
| Elig Criteria Explained | Yes (true) | EligCriteriaExplainedInd |
| FPG Used Deter Elig Free Care | Yes (true) | FPGUsedDeterEligFreeCareInd |
| FPG Family Incm Lmt Free Care | 400. | FPGFamilyIncmLmtFreeCarePct |
| FPG Used Determ Elig Dscnt Care | Yes (true) | FPGUsedDetermEligDscntCareInd |
| FPG Family Incm Lmt Dscnt Care | 400. | FPGFamilyIncmLmtDscntCarePct |
| Explained Basis | Yes (true) | ExplainedBasisInd |
| Income Level | Yes (X) | IncomeLevelInd |
| Asset Level | Yes (X) | AssetLevelInd |
| Medical Indigency | Yes (X) | MedicalIndigencyInd |
| Insurance Status | Yes (X) | InsuranceStatusInd |
| Uninsured Discount | Yes (X) | UninsuredDiscountInd |
| Medicaid Medicare | Yes (X) | MedicaidMedicareInd |
| State Regulation | Yes (X) | StateRegulationInd |
| App Financial Asst Expln | Yes (true) | AppFinancialAsstExplnInd |
| Includes Publicity Measures | Yes (true) | IncludesPublicityMeasuresInd |
| Posted On Website | Yes (X) | PostedOnWebsiteInd |
| Attached To Invoice | Yes (X) | AttachedToInvoiceInd |
| Posted In Emergency Room | Yes (X) | PostedInEmergencyRoomInd |
| Posted In Admission Office | Yes (X) | PostedInAdmissionOfficeInd |
| Provided On Admission | Yes (X) | ProvidedOnAdmissionInd |
| Available On Request | Yes (X) | AvailableOnRequestInd |
| FAP Actions On Nonpayment | Yes (true) | FAPActionsOnNonpaymentInd |
| Collection Activities | false | CollectionActivitiesInd |
| Nondis Emergency Care Policy | Yes (true) | NondisEmergencyCarePolicyInd |
| Other Method Used | Yes (X) | OtherMethodUsedInd |
| Amounts Generally Billed | false | AmountsGenerallyBilledInd |
| Gross Charges | false | GrossChargesInd |
Supplemental Information SupplementalInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | schedule h, part v, section b, line 3: | FormAndLineReferenceDesc |
| Explanation | To gain a better understanding of needs in Mission Hill specifically, the consultants worked with the Mass. Eye and Ear CB Working Group and with Brigham and Women's Hospital Community Benefits leaders to identify Mission Hill service providers, advocates and educators positioned to speak to the needs of the community. The consultants then conducted ten in-depth interviews with the identified key informants. (See Figure 12 in the official MEEI Community Benefits Report for the key informant interview participants and their organizational affiliations.) Among them was a member of the New England Baptist Hospital, which operates a smaller but highly regarded community benefits program targeting Mission Hill. The experiences of the BWH and New England Baptist provided great insights that informed the assessment and planning processes described below. The interviews yielded important and useful information about neighborhood characteristics, methods for building and sustaining strong relationships in Mission Hill, the needs of the neighborhood, and partnership opportunities. Schedule H, Part V, Section B, Line 6a: The implementation strategy can be found within the community health needs assessment online at the MEEI website, www.masseyeandear.org. Schedule H, Part V, Section B, Line 7: Mass. Eye and Ear's strategies proved successful at achieving our annual targets and supporting our community benefits objectives. The CHNA includes tables that display the expected outcomes/targets established for the year and describe our progress in meeting those targets. In most cases, targets were either met or exceeded. In cases in which targets were not been met, information is provided to explain why our progress fell short of the targets and to describe our quality improvement plans, if needed, to ensure that we are able to meet our targets moving forward. Targets Missed: -At least 50 young adults will received comprehensive eye exams. Only 35 young adults receive exams through vision coalition. -Provide self-defense training to at least 10 individuals with blindness or vision impairment. None received training because group disbanded during the fiscal year. -At least 50 people will be screen for head/neck cancer. We allocated space for 50 patients but only 40 people were screened at the Head and Neck Cancer Screening/Table. -Mass. Eye and Ear patients who need assistance with lodging, food, and other vital necessities will receive help in securing those resources. Only 30 people received assistance securing resources. MEEI believes more people have access to the internet are handling these needs by themselves. We assisted all who requested assistance. -AT LEAST 2,500 PEOPLE WHO REQUIRE FREE PARKING WILL RECEIVE IT. ONLY 200 PEOPLE RECEIVED FREE PARKING. WE LOST CONTROL OF OUR PARKING LOT LEASE AND NO LONGER PROVIDE FREE PARKING TO SOME COMMUNITY GROUPS. WE WILL ADJUST TARGET FOR NEXT YEAR SINCE WE DO NOT HAVE CONTROL OVER THE LOTS ANYMORE. SCHEDULE H, PART V, SECTION B, LINE 20D: CHARGES FOR PATIENTS WHO QUALIFY FOR FINANCIAL ASSISTANCE ARE BASED ON THE AVERAGE REIMBURSEMENT OF THE INFIRMARY'S THREE LARGEST PAYERS. | ExplanationTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Facility | 9 | FacilityNum |
Oth Hlth Care Fclts Not Hospital OthHlthCareFcltsNotHospitalGrp
Oth Hlth Care Fclts OthHlthCareFcltsGrp (9 entries)
| Address Line1USAddress/AddressLine1 | CityUSAddress/City | StateUSAddress/State | ZIP CodeUSAddress/ZIPCode | FacilityFacilityTxt |
|---|---|---|---|---|
| MASSACHUSETTS EYE & EAR STONEHAM | ||||
| ONE MONTVALE AVENUE | STONEHAM | MA | 02180 | LICENSED OUTPATIENT LOCATION |
| MASSACHUSETTS EYE & EAR E BRIDGEWATER | ||||
| ONE COMPASS WAY SUITE 100 | E BRIDGEWATER | MA | 02333 | LICENSED OUTPATIENT LOCATION |
| MEEI VESTIBULAR CENTER AT BRAINTREE | ||||
| 250 POND STREET 1ST FLOOR | BRAINTREE | MA | 02184 | LICENSED OUTPATIENT LOCATION |
| MASSACHUSETTS EYE & EAR QUINCY | ||||
| 500 CONGRESS STREET | QUINCY | MA | 02169 | LICENSED OUTPATIENT LOCATION |
| MASSACHUSETTS EYE & EAR AT JOSLIN | ||||
| 1 JOSLIN PLACE | BOSTON | MA | 02215 | LICENSED OUTPATIENT LOCATION |
| MEE CONCORD SIGHT (AUDIOLOGY ONLY) | ||||
| 54 BAKER AVE EXTENSION 3RD FL STE | CONCORD | MA | 01742 | LICENSED OUTPATIENT LOCATION |
| MASSACHUSETTS EYE & EAR LONGWOOD | ||||
| 800 HUNTINGTON AVENUE | BOSTON | MA | 02115 | LICENSED OUTPATIENT LOCATION |
| MASSACHUSETTS EYE & EAR MEDFORD | ||||
| 101 MAIN STREET | MEDFORD | MA | 02115 | LICENSED OUTPATIENT LOCATION |
| MASSACHUSETTS EYE & EAR PLAINVILLE | ||||
| 30 MAN MAR DRIVE STE 2 | PLAINVILLE | MA | 02762 | LICENSED OUTPATIENT LOCATION |
Supplemental Information Detail SupplementalInformationDetail (15 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| SCHEDULE H, PART I, LINE 7A: | IN FY14, MASSACHUSETTS EYE AND EAR INFIRMARY ("THE INFIRMARY") RECEIVED PAYMENTS FROM THE MASSACHUSETTS HEALTH SAFETY NET IN CONNECTION WITH FINANCIAL ASSISTANCE EXPENSES INCURRED IN FY13. THE COMMUNITY BENEFIT PERCENTAGE REPORT ON SCHEDULE H, PART I, LINE 7A DECREASED 1.41% FROM THE PRIOR YEAR AMOUNT DUE TO THIS RETROACTIVE PAYMENT. SCHEDULE H, PART II: THE INFIRMARY AND ITS AFFILIATED ORGANIZATIONS (COLLECTIVELY "MEEI") PROVIDED COMMUNITY BUILDING HEALTH IMPROVEMENT ADVOCACY BY PROVIDING EDUCATIONAL OPPORTUNITIES AND SUPPORT, INCLUDING HOSTED SUPPORT GROUPS, FOCUSING ON HEALTH CONDITIONS IN OUR SPECIALTIES TO PATIENTS AND THE PUBLIC. PLEASE SEE PAGE 16 OF THE COMMUNITY BENEFITS PLAN POSTED ON THE MEEI WEBSITE, WWW.MASSEYEANDEAR.ORG, FOR DETAILS. WWW.MASSEYEANDEAR.ORG, FOR DETAILS. |
| SCHEDULE H, PART III, LINEs 2-4: | BAD DEBTS ARE WRITTEN OFF AT GROSS CHARGES. FOR UNINSURED CLAIMS (SELF-PAY), BAD DEBTS ARE DISCOUNTED TO COST USING THE HOSPITAL COST ACCOUNTING SYSTEM. ACCOUNTS RECEIVABLE RELATED TO CO-PAYS, DEDUCTIBLES, AND COINSURANCE THAT IS WRITTEN OFF AS BAD DEBT IS ALREADY REPORTED AT COST AND IS DEDUCTED FROM THE INSURANCE-ALLOWED AMOUNT. SEE FINANCIAL STATEMENT, PAGE 24-25. |
| SCHEDULE H, PART III, LINE 8: | THE SHORTFALL REPORTED ON PART III, LINE 7 SHOULD BE CONSIDERED COMMUNITY BENEFIT BECAUSE REIMBURSEMENT FROM MEDICARE DOES NOT COVER THE COST OF TREATING PATIENTS. MEEI HAS A POLICY TO TREAT ALL PATIENTS, REGARDLESS OF THE PAYER. AS A PRIMARILY OUT-PATIENT FACILITY, WITH ONLY TWO SPECIALTIES, MEEI CANNOT BENEFIT FROM RELATIVELY HIGHER MEDICARE PAYMENTS FOR SOME SPECIALTIES OR HIGHER INPATIENT MEDICARE REIMBURSEMENT. WITHOUT COMPROMISING PATIENT CARE, MEEI HAS LIMITED MEANS FOR REDUCING COSTS. MEEI USES A COST ACCOUNTING SYSTEM THAT IS COMPRISED OF A STEP-DOWN METHODOLOGY FOR ALLOCATING HOSPITAL OVERHEAD THAT IS SIMILAR TO THAT USED FOR THE MEDICARE COST REPORT. ALL INDIRECT COSTS ARE ALLOCATED TO PATIENT CARE COST CENTER, TEACHING AND RESEARCH. FULLY-LOADED PATIENT CARE COSTS ARE ALLOCATED TO PATIENTS USING BILLED UNITS, UNIT COSTS, AND ALLOCATION ALGORITHMS SPECIFIC TO EACH COST CENTER. |
| SCHEDULE H, PART III, LINE 9B: | PATIENTS ARE NOTIFIED ON ALL BILLING STATEMENTS OF THE AVAILABILITY OF FINANCIAL ASSISTANCE AND THE CONTACT INFORMATION OF THE APPROPRIATE STAFF MEMBERS WHO ARE AVAILABLE TO ASSIST IN THE PROCESS. MEEI'S POLICY INCORPORATES SPECIFIC BILLING PRACTICES RELATING TO PATIENTS WHO ARE ELGIBILE FOR FINANCIAL ASSISTANCE. |
| SCHEDULE H, PART VI, LINE 2: | MEEI ENGAGED THE SERVICES OF CONSULTANTS TO WORK CLOSELY WITH THE COMMUNITY BENEFITS (BC) WORKING GROUP THROUGHOUT THE ASSESSMENT AND PLANNING PROCESS, WHICH TOOK PLACE DURING THE FALL 2012/WINTER 2013. DURING THE ASSESSMENT AND PLANNING PROCESSES, THE CB WORKING GROUP MET REGULARLY AND ENGAGED THE FULL COMMITTEE AS NEEDED FOR PROGRESS UPDATES AND INPUT. AFTER THE PLAN WAS DEVELOPED AND APPROVED, MEETINGS DECREASED IN FREQUENCY AND THE GROUPS MET ON AN AS-NEEDED BASIS. FOR MOST MASSACHUSETTS HOSPITALS, COMMUNITY-LEVEL DATA AVAILALBE THROUGH THE MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH AND BOSTON PUBLIC HEALTH COMMISSION ARE USEFUL IN UNDERSTANDING THE SPECIFIC HEALTH NEEDS OF COMMUNITIES AND THOSE IN WHICH DISPARITIES EXIST. THESE DATA ARE TYPICALLY USED TO SELECT VULNERABLE COMMUNITIES AND POPULATIONS AND TO TARGET SERVICES TO ADDRESS PARTICULAR HEALTH ISSUES AND DISPARITIES. BECAUSE NEITHER THE BOSTON PUBLIC HEALTH COMMISSION NOR THE MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH COLLECT AND REPORT DATA ON VISION, HEARING AND OTHER HEAD AND NECK CONDITIONS IN MASSACHUSETTS COMMUNITIES, MEEI'S CB COMMITTEE HAD TO RELY ON ITS OWN PATIENT DATA, CENSUS DATA, AND GUIDANCE FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION TO DEFINE ITS TARGET COMMUNITIES AND POPULATIONS AND TO FORMULATE OBJECTIVES FOR ITS COMMUNITY BENEFITS PLAN. |
| SCHEDULE H, PART VI, LINE 3: | MEEI, AS A FACILITY, WORKS TO ACTIVELY INFORM PATIENTS OF PROGRAMS AND RESOURCES AVAILABLE TO THEM TO HELP WITH FINANCIAL ASSISTANCE. BILLING BROCHURES ARE AVAILABLE IN ALL DEPARTMENTAL WAITING AREAS, WHICH EXPLAIN THE BILLING PROCESS AND THE PATIENT'S OPTIONS FOR FINANCIAL ASSISTANCE. IN ADDITION, THE MEEI EXTERNAL WEBSITE CONTAINS A LINK WHICH HIGHLIGHTS THE BASIC FEDERAL PROGRAMS AND ACCESS TO MEEI'S FINANCIAL COUNSELORS. THE FINANCIAL COUNSELING PROCESS IS DESIGNED TO EVALUATE THE PATIENTS' FINANCIAL ABILITY TO PAY AND TO RECOMMEND AND ASSIST THE PATIENT WITH ENROLLING IN ANY APPLICABLE GOVERNMENT OR PRIVATE PROGRAMS. WHEN ALL AVENUES HAVE BEEN EXHAUSTED, CHARITABLE CARE CRITERIA ARE REVIEWED. |
| SCHEDULE H, PART VI, LINE 4: | STEP 1: IDENTIFY MEEI'S TARGET AREA AND POPULATIONS FOR ITS COMMUNITY BENEFITS PLAN THE ASSESSMENT TO INFORM THE NEXT MEEI COMMUNITY BENEFIT PLANS BEGAN WITH ANALYSIS OF 12 MONTHS OF PATIENT DATA (APRIL 1, 2011 THROUGH MARCH 31, 2012) TO BETTER UNDERSTAND THE POPULATION SERVED. PATIENTS FROM OUTSIDE OF MASSACHUSETTS WERE EXCLUDED FROM ANALYSES, LEAVING A REPRESENTATIVE SAMPLE OF 65,429 PATIENTS. BELOW, OBSERVATIONS ABOUT PATIENTS' SEX, RACE/ETHNICITY, AGE, SOCIO-ECONOMIC STATUS, AND THEIR GEOGRAPHIC LOCATIONS ARE PROVIDED. THESE DATA WERE USED TO GUIDE THE SELECTION OF COMMUNITIES AND/OR POPULATIONS OF FOCUS. DEMOGRAPHIC CATEGORIES & STATISTICS: SEX: OVER HALF (53.4%) OF PATIENTS INCLUDED IN THE DATA SET ARE FEMALE. RACE/ETHNICITY: ROUGHLY 75% OF PATIENTS IN THE SAMPLE ELECTED TO PROVIDE DATA ABOUT THEIR RACE AND ETHNICITY AT THE TIME OF REGISTRATION AT THE HOSPITAL. FIGURE 1 BELOW SHOWS THE RACIAL/ETHNIC BREAKDOWN OF PATIENTS IN THE DATA SET, THE MAJORITY OF WHOM (60.2%) ARE WHITE. RACIAL/ETHNIC BREAKDOWN: (NUMBER OF PATIENTS; PERCENTAGE OF TOTAL PATIENTS) AMERICAN INDIAN/ALASKA NATIVE: 125; 0.2% ASIAN: 2,196; 3.4% BLACK/AFRICAN AMERICAN: 4,684; 7.2% HISPANIC: 1,090; 1.7% PACIFIC ISLANDER: 25; <1% WHITE: 39,392; 60.2% OTHER: 1,148; 1.7% UNKNOWN: 16,769; 25.6% TOTAL: 65,429; 100% BECAUSE THERE IS SO MUCH MISSING INFORMATION ABOUT RACE/ETHNICITY, THE DATA WERE NOT PARTICULARLY USEFUL IN IDENTIFYING VULNERABLE POPULATIONS. GEOGRAPHY: NOTE THAT WITHIN DATA SET, SOME PATIENTS WERE LISTED AS LIVING IN BOSTON WITH NO SPECIFIED NEIGHBORHOOD, WHEREAS OTHERS WERE LISTED AS LIVING IN ONE OF BOSTON'S 21 NEIGHBORHOODS. IN FACT, DATA WERE AVAILABLE FOR 11 OF THE 21 NEIGHBORHOODS. RATHER THAN ROLL THE DATA FOR THE 11 NEIGHBORHOODS INTO THE BOSTON NUMBERS, THE CONSULTANTS KEPT THE DATA SEPARATE TO UNDERSTAND WHICH NEIGHBORHOODS HAVE SIGNIFICANT NUMBERS OF MEEI PATIENTS. HOWEVER, IT SHOULD BE NOTED THAT THE ACTUAL NUMBERS ASSOCIATED WITH THOSE NEIGHBORHOODS SHOULD BE HIGHER, AS SOME PATIENTS LIVING IN THOSE NEIGHBORHOODS ARE SIMPLY CLASSIFIED AS LIVING IN BOSTON. OTHER NEIGHBORHOODS OF BOSTON MAY ALSO BE HOME TO LARGE NUMBERS OF MEEI PATIENTS BUT, BECAUSE THEY ARE NOT BROKEN OUT, WE DO NOT KNOW HOW MANY PATIENTS RESIDE IT THOSE NEIGHBORHOODS. OF THE 65,429 MASSACHUSETTS PATIENTS IN THE DATA SET, NEARLY 30% LIVE IN BOSTON AND NEARLY HALF (49.2%) LIVE IN COMMUNITIES INSIDE ROUTE 128 (INCLUDING BOSTON). THE VAST MAJORITY (82.8%) OF PATIENTS ARE FROM COMMUNITIES INSIDE OF ROUTE 495. PERCENT OF MEEI PATIENTS LIVING IN GEOGRAPHIC AREAS OF MASSACHUSETTS: BOSTON/BOSTON NEIGHBORHOODS: 29.5% WITHIN 128 (EXCEPT BOSTON): 19.7% NORTH SHORE: 3.2% INSIDE 495 (BEYOND 128): 30.4% OUTSIDE 495 - CENTRAL: 6.6% OUTSIDE 495 - NORTH: 4.5% WESTERN MA: 5.1% CAPE/ISLANDS: <1% TO IDENTIFY POPULATION CENTERS, THE CONSULTANTS LOOKED FOR THE COMMUNITIES/NEIGHBORHOODS IN WHICH THE LARGEST NUMBERS OF MEEI PATIENTS LIVE. FIFTEEN COMMUNITIES/NEIGHBORHOODS ARE HOME TO THE LARGEST NUMBERS OF MEEI PATIENTS. NEARLY HALF (49.9%) LIVE IN THESE 15 COMMUNITIES. MASSACHUSETTS COMMUNITIES/NEIGHBORHOODS WITH HIGHEST PROPORTION OF MEEI PATIENTS: (COMMUNITY: NUMBER OF PATIENTS; PERCENTAGE OF TOTAL PATIENTS; GEOGRAPHIC AREA) BOSTON (NO COMMUNITY SPECIFIED): 12,575; 19.2%; BOSTON JAMAICA PLAIN: 1,007; 1.5%; BOSTON WEST ROXBURY: 817; 1.2%; BOSTON ROSLINDALE: 789; 1.2%; BOSTON HYDE PARK: 780; 1.2%; BOSTON ALLSTON/BRIGHTON: 1,414; 2.2%; BOSTON CHARLESTOWN: 1,188; 1.8%; BOSTON CAMBRIDGE: 4,037; 6.2%; WITHIN 128 LYNN: 3,941; 6.0%; WITHIN 128 WAKEFIELD: 911; 1.4%; WITHIN 128 WOBURN: 933; 1.4%; WITHIN 128 READING/N. READING: 1,180; 1.8%; INSIDE 495 ANDOVER/N. ANDOVER: 1,356; 2.1%; INSIDE 495 FRAMINGHAM: 941; 1.4%; INSIDE 495 WORCESTER: 752; 1.1%; OUTSIDE 495 AGE: THE MASSACHUSETTS ATTORNEY GENERAL IS INTERESTED IN HAVING THE HOSPITAL COMMUNITY BENEFITS PLANS TARGET VULNERABLE POPULATIONS. MEEI HAS CLINICAL EXPERTISE IN SERVING ELDERS AND CHILDREN, POTENTIALLY VULNERABLE POPULATIONS SELECTED BY THE COMMUNITY BENEFITS STEERING COMMITTEE AS PRIORITY POPULATIONS FOR MEEI'S COMMUNITY BENEFITS PLAN BECAUSE OF THE IMPACT OF HEARING/VISION IMPAIRMENT ON CHILDREN'S DEVELOPMENT AND HEARING/VISION IMPAIRMENT AND BALANCE ISSUES ON THE HEALTH AND SAFETY OF ELDERS. THE MEAN AGE OF MEEI PATIENTS IS 46.81 YEARS, WITH A RANGE OF LESS THAN ONE YEAR OF AGE TO 106 YEARS OF AGE. PATIENTS AGED 65 AND OVER MAKE UP 23.5% OF THOSE SEEN DURING THE SELECTED TIMEFRAME, WHEREAS THOSE 18 OR YOUNGER CONSTITUTE 13.7% OF THE POPULATION. BELOW SHOWS THE PROPORTION OF PATIENTS IN VARIOUS AGE GROUPS: (AGE GROUP: PERCENTAGE OF TOTAL) <1 YEAR TO 18 YEARS OLD: 13.7% 19 TO 24 YEARS OLD: 5.4% 25 TO 34 YEARS OLD: 10.6% 35 TO 44 YEARS OLD: 12.2% 45 TO 54 YEARS OLD: 16.3% 55 TO 64 YEARS OLD: 18.3% 65 AND OVER: 23.5% TEN COMMUNITIES ARE HOME TO THE LARGEST NUMBER OF MEEI'S SENIOR (65 YEARS AND OLDER) POPULATION. THESE TEN COMMUNITIES ARE HOME TO 34% OF MEEI SENIORS: (COMMUNITY: NUMBER OF PATIENTS; PERCENTAGE OF TOTAL) BOSTON (NO COMMUNITY SPECIFIED): 1,820; 11.8% CAMBRIDGE: 1,015; 6.6% DORCHESTER: 540; 3.5% LYNN: 386; 2.5% BRIGHTON: 298; 1.9% FRAMINGHAM: 261; 1.7% JAMAICA PLAIN: 238; 1.5% PEABODY: 237; 1.5% SAUGUS: 227; 1.5% WOBURN: 227; 1.5% TEN COMMUNITIES ARE HOME TO THE LARGEST NUMBERS OF MEEI PATIENTS WHO ARE LESS THAN 1 YEAR OF AGE THROUGH AGE 18. NEARLY 30% OF THE CHILDREN SERVED BY MEEI DURING THE DESIGNATED TIME PERIOD LIVE IN THESE TEN COMMUNITIES: (COMMUNITY: NUMBER OF PATIENTS; PERCENTAGE OF TOTAL) BOSTON (NO COMMUNITY SPECIFIED): 883; 9.9% LYNN: 370; 4.1% CAMBRIDGE: 350; 3.9% SAUGUS: 192; 2.1% CHARLESTOWN: 175; 2.0% WOBURN: 169; 1.9% HAVERHILL: 143; 1.6% ANDOVER: 141; 1.6% DORCHESTER: 131; 1.4% READING: 129; 1.4% SOCIO-ECONOMIC STATUS: SOCIO-ECONOMIC (SES) IS ANOTHER VARIABLE ASSOCIATED WITH VULNERABLE POPULATIONS. PATIENTS' HEALTH INSURANCE CAN BE USED AS A PROXY FOR SES BECAUSE THERE ARE INCOME ELIGIBILITY REQUIREMENTS IN PLACE FOR PUBLIC PAYERS THAT ALLOW US TO MAKE ASSUMPTIONS ABOUT WHICH PATIENTS ARE LOW INCOME. IT IS IMPORTANT TO NOTE THAT THE NUMBER OF LOW-INCOME PATIENTS SERVED BY MEEI IS LIKELY MUCH HIGHER. IT IS NOT POSSIBLE TO KNOW HOW MANY MASSHEALTH PATIENTS, FOR EXAMPLE, ARE INSURED THROUGH A COMMERCIAL CARRIER WITH A MANAGED CARE CONTRACT WITH MASSHEALTH. ADDITIONALLY, IT IS NOT POSSIBLE TO KNOW WHICH PORTION OF THE SENIORS USING MEDICARE PRODUCTS TO PAY FOR THE SERVICES THEY RECEIVE AT MEEI ARE LOW-INCOME AND WHICH ARE NOT. ALTHOUGH AN IMPERFECT METHOD FOR DETERMINING THE SES OF PATIENTS, THESE ARE THE BEST DATA AVAILABLE FOR THIS PURPOSE. USING PAYER AS PROXY, IT APPEARS THAT JUST OVER 11% OF THE MEEI PATIENTS ARE LOW-INCOME, BROKEN DOWN AS FOLLOWS: |
| (PUBLIC PAYER: NUMBER OF PATIENTS; PERCENTAGE OF TOTAL) | MASSHEALTH: 3,672; 7.1% HEALTH SAFETY NET: 796; 1.2% MEDICAID: 287; 0.4% BMC HEALTH NET: 143; 0.2% NETWORK HEALTH: 1,493; 2.3% THE AVERAGE AGE OF THESE LOW-INCOME PATIENTS IS 37 WITH A RANGE OF LESS THAN ONE YEAR OF AGE TO 96 YEARS OF AGE. IT IS IMPORTANT TO NOTE THAT THE VAST MAJORITY OF SENIORS (65+) ARE EXCLUDED FROM THE ANALYSES BECAUSE MOST SENIORS USE MEDICARE PRODUCTS TO PAY FOR THEIR CARE. TEN COMMUNITIES ARE HOME TO THE LARGEST NUMBERS OF MEEI PATIENTS WHO HAVE LOW SES. NEARLY 50% OF THE PATIENTS WITH LOW SES LIVE IN THESE TEN COMMUNITIES: (COMMUNITY: NUMBER OF PATIENTS; PERCENTAGE OF TOTAL) BOSTON (NO COMMUNITY SPECIFIED): 1,102; 17.2% LYNN: 504; 7.9% CAMBRIDGE: 440; 6.9% DORCHESTER: 248; 3.8% LAWRENCE: 198; 3.1% CHARLESTOWN: 160; 2.5% EAST BOSTON: 163; 2.2% SAUGUS: 129; 2.0% LOWELL: 127; 2.0% WORCESTER: 123; 1.9% MEEI SERVES A POPULATION WITH A LARGE AGE RANGE, INCLUDING SIGNIFICANT SENIOR (65+) AND PEDIATRIC (LESS THAN ONE YEAR THROUGH AGE 18) POPULATIONS. USING PATIENT PAYER AS A PROXY FOR SES, AT LEAST 11.2% OF THE PATIENTS HAVE LOW SES. NEARLY HALF OF MEEI'S PATIENTS LIVE IN COMMUNITIES WITHIN ROUTE 128, INCLUDING BOSTON AND SELECT NEIGHBORHOODS. ELEVEN OF THE 15 COMMUNITIES THAT ARE HOME TO THE LARGEST CONCENTRATION OF MEEI PATIENTS ARE WITHIN THIS GEOGRAPHIC AREA. THERE IS OVERLAP IN THE TOP COMMUNITIES FOR THE GENERAL POPULATION OF PATIENTS SEEN DURING THE DESIGNATED TIMEFRAME AND THE VULNERABLE POPULATIONS. THREE ARE AMONG THE TOP COMMUNITIES FOR THE OVERALL POPULATION AND ELDERS, CHILDREN AND THOSE WITH LOW-SES: BOSTON, CAMBRIDGE AND LYNN. TWO OTHERS (DORCHESTER AND SAUGUS) ARE AMONG THE TOP TEN FOR ALL THREE VULNERABLE GROUPS. IT MAY BE POSSIBLE TO MAXIMIZE RESOURCES FOR ADDRESSING THE NEEDS OF PATIENTS OVERALL AND AMONG THE VULNERABLE POPULATIONS BY CONCENTRATING EFFORTS IN COMMUNITIES/NEIGHBORHOODS WITHIN 128, ESPECIALLY THOSE WHERE SUCH OVERLAPS EXIST. A 2010 CENSUS MAP PRODUCED BY THE BOSTON GLOBE AND AVAILABLE ON-LINE SHOWS THAT THE LARGEST CONCENTRATION OF PEOPLE OF COLOR IN MASSACHUSETTS IS IN THE METRO BOSTON AREA. A SIMILAR 2010 CENSUS MAP SHOWS THAT, ALTHOUGH METRO BOSTON IS HOME TO SOME OF THE COMMONWEALTH'S WEALTHIEST COMMUNITIES, IT IS ALSO HOME TO SOME OF THE LOWEST INCOME COMMUNITIES. A THIRD MAP CREATED BY THE GERONTOLOGY INSTITUTE AT THE MCCORMACK GRADUATE SCHOOL OF POLICY AND GLOBAL STUDIES AT THE UNIVERSITY OF MASSACHUSETTS BOSTON SHOWS THAT THE POPULATION OF SENIORS LIVING WITHIN THE METRO BOSTON AREA EXCEEDS THE STATEWIDE AVERAGE. ACCORDING TO THE 2010 CENSUS, 13.8% OF MASSACHUSETTS RESIDENTS ARE AGED 65 AND OLDER. WITHIN THE MAJORITY OF METRO BOSTON COMMUNITIES, SENIORS COMPRISE BETWEEN 15.1% AND 20% OF THE CITY/TOWN POPULATIONS. CONCLUSIONS: BASED ON THE MOST RECENT CENSUS DATA AND MEEI'S OWN PATIENT DATA, THE COMMUNITY BENEFITS COMMITTEE CONCLUDED THAT, ALTHOUGH MEEI CARES FOR PATIENTS FROM ALL OVER THE COMMONWEALTH, THE HOSPITAL'S PRIMARY SERVICE AREA INCLUDES THE COMMUNITIES IN THE METRO-BOSTON AREA (WITHIN THE ROUTE 128 BELT). ANALYSES ALSO SHOWED THAT LARGE NUMBERS OF VULNERABLE (I.E., CHILDREN, ELDERLY AND LOW-INCOME) PATIENTS RESIDE WITHIN THE METRO-BOSTON/128 AREA. THE COMMITTEE FURTHER CONCLUDED THAT, GIVEN THE NUMBER OF LOW INCOME COMMUNITIES AND PROPORTION OF PEOPLE OF COLOR RESIDING WITHIN ITS PRIMARY SERVICE AREA, MEMBERS OF MEEI'S TARGET POPULATION ARE VERY LIKELY TO EXPERIENCE BARRIERS TO CARE RELATED TO DIVERSITY (E.G., LANGUAGE) AND SOCIO-ECONOMIC FACTORS. BECAUSE OF THE FACTORS THAT MAKE CHILDREN, SENIORS AND LOW-INCOME INDIVIDUALS PARTICULARLY VULNERABLE, THESE GROUPS WILL BE PRIORITIZED WITHIN THE COMMUNITY BENEFITS PLAN. ALTHOUGH THE PLAN SHOULD NOT EXCLUDE THOSE LIVING OUTSIDE THE METRO-BOSTON AREA, IT SHOULD EMPHASIZE SERVICES FOR THOSE LIVING WITHIN IT BECAUSE RESIDENTS ARE SO LIKELY TO EXPERIENCE BARRIERS TO CARE. MEEI SHOULD BUILD UPON A SOLID FOUNDATION OF OUTREACH AND SERVICE PROVISION TO METRO-BOSTON COMMUNITIES AND INCLUDE STRATEGIES FOR IMPROVING ACCESS TO CARE IN THE COMMUNITY BENEFITS PLAN. |
| STEP 2: ASSESS UNMET NEEDS IN METRO BOSTON AND AMONG THE TARGET | POPULATIONS THE CB WORKING GROUP, OTHER MEMBERS OF THE COMMUNITY BENEFITS COMMITTEE, OTHER PROVIDERS AND STAFF AT MEEI, AND EXTERNAL PARTNERS AT ORGANIZATIONS SERVING THE TARGET POPULATIONS AND COMMUNITIES WORKED TOGETHER TO UNDERSTAND THE UNMET NEEDS THAT, AS AN INSTITUTION, MEEI IS UNIQUELY POSITIONED TO ADDRESS BECAUSE OF ITS CLINICAL SERVICES AND EXPERTISE. THROUGH ON-GOING DIALOG AND CONVERSATIONS OVER THE SUMMER AND FALL OF 2012, THE CB WORKING GROUP LED THE PROCESS TO IDENTIFY THE RESOURCE NEEDS. THE NEEDS ARE CONSISTENT WITH THOSE IDENTIFIED IN THE 2010 COMMUNITY BENEFITS PLAN: -TO EXTEND VISION SCREENING AND HEARING EXAMINATIONS AND FOLLOW UP CARE TO INDIVIDUALS WHO HAVE NO OR VERY LIMITED ACCESS TO SUCH SERVICES. -FOR RECONSTRUCTIVE SURGICAL SERVICES FOR SURVIVORS OF DOMESTIC VIOLENCE WHO EXPERIENCED PHYSICAL INJURIES TO THE HEAD AND/OR NECK AS A RESULT OF ABUSE. -FOR EDUCATION, SCREENING AND SUPPORT FOR HEAD AND NECK CANCERS. -FOR EDUCATION AND SUPPORT RELATED TO FACIAL PARALYSIS AND CONDITIONS THAT AFFECT SMELL AND TASTE. -FOR RESOURCES TO IMPROVE ACCESS TO CARE FOR MEMBERS OF THE TARGET COMMUNITIES WHO WOULD BENEFIT FROM MEEI SERVICES BUT WHO ARE UNABLE TO GET THE CARE THEY NEED DUE TO LINGUISTIC OR FINANCIAL ISSUES, LACK OF TRANSPORTATION, OR A LACK OF KNOWLEDGE ABOUT THEIR CONDITIONS AND THE SERVICES TO ADDRESS THEM. -FOR FINANCIAL SUPPORT OF COMMUNITY-BASED NON-PROFITS ENGAGED IN UNIQUE AND HIGH QUALITY WORK TO ADDRESS VISION, HEARING OR OTHER CONCERNS OF THE HEAD AND NECK IN THE TARGET COMMUNITIES AND/OR AMONG THE TARGET POPULATIONS. WITH GROWTH IN THE SENIOR POPULATION, THE INCREASE IN POVERTY OVER THE LAST SEVERAL YEARS, AND THE SMALL NUMBER OF INSTITUTIONS OFFERING THE CLINICAL EXPERTISE AND SERVICES AVAILABLE AT MEEI WITHIN METRO BOSTON, THE COMMUNITY BENEFITS COMMITTEE CONCLUDED THAT THE NEEDS ARE LIKELY TO PERSIST FOR MANY YEARS TO COME. SOME OF THE IDENTIFIED NEEDS (I.E., THOSE RELATED TO AWARENESS AND EDUCATION) AFFECT LARGE NUMBERS OF PEOPLE IN THE TARGET AREA. OTHERS AFFECT SMALLER GROUPS OF PEOPLE, EITHER BECAUSE POCKETS OF PEOPLE EXPERIENCE IMPEDED ACCESS TO SERVICES THAT ARE OTHERWISE GENERALLY AVAILABLE OR BECAUSE A CLINICAL CONDITION IS RARE AND THE RESOURCES TO ADDRESS IT ARE EXTREMELY LIMITED. CONCLUSION: THE COMMUNITY BENEFITS COMMITTEE CONCLUDED THAT THE UNMET NEEDS IDENTIFIED DURING THE METRO BOSTON ASSESSMENT WERE ALIGNED WITH THE CAPABILITIES OF MEEI AND ITS COMMUNITY PARTNERS AND SHOULD BE USED TO FORMULATE GOALS FOR MEEI'S COMMUNITY BENEFITS PLAN. STEP 3: ASSESS NEEDS IN MISSION HILL AS NOTED EARLIER, MEEI DECIDED TO BROADEN ITS COMMUNITY BENEFITS WORK TO PROVIDE TARGETED PROGRAMMING IN MISSION HILL, THE NEIGHBORHOOD IN WHICH ITS NEW OUT-PATIENT FACILITY IS LOCATED. MISSION HILL IS ONE SQUARE MILE, THREE-QUARTERS OF WHICH IS RESIDENTIAL. THE OTHER QUARTER IS COMPRISED OF THE LONGWOOD MEDICAL AREA. ACCORDING TO A REPORT BASED ON 2010 CENSUS DATA, MISSION HILL IS HOME TO 16,305 RESIDENTS, 19.7% OF WHOM ARE HISPANIC/LATINO. JUST UNDER 46% OF THE POPULATION IS A RACE OTHER THAN WHITE. ROUGHLY 21% OF THE MISSION HILL POPULATION IS 19 YEARS OF AGE OR YOUNGER AND 9.1% IS 65 YEARS OF AGE OR OLDER. AN AMERICAN COMMUNITY SURVEY (2005-2009) ESTIMATE REPORT ESTIMATES THAT 3,711 OR 28.1% OF MISSION HILL RESIDENTS WERE BORN OUTSIDE OF THE U.S. AND THAT 48.5% OF THOSE ARE NOT CURRENTLY U.S. CITIZENS. JUST OVER 44% OF RESIDENTS SPEAK A LANGUAGE OTHER THAN OR IN ADDITION TO ENGLISH. OF THOSE WHO SPEAK A LANGUAGE OTHER THAN ENGLISH, 33.2% ARE LINGUISTICALLY ISOLATED BECAUSE THEY SPEAK LITTLE OR NO ENGLISH. IN 2009, AN ESTIMATED 19.3% OF MISSION HILL RESIDENTS EARNED LESS THAN $10,000 A YEAR. MORE THAN HALF (53.6%) EARNED LESS THAN $40,000 PER YEAR. IN CONTRAST, 12.6% EARNED $100,000 OR MORE IN THE SAME 12 MONTHS. ACCORDING TO THE 2010 CENSUS, OF THE 6,332 OCCUPIED HOUSING UNITS IN MISSION HILL, ONLY 11.4% ARE OWNER-OCCUPIED AND 33.6% ARE OCCUPIED BY FAMILIES. SEVERAL HUNDRED HOUSING UNITS IN MISSION HILL ARE OWNED AND RENTED BY THE BOSTON HOUSING AUTHORITY. SENIORS (65+) RESIDE IN 17.8% OF MISSION HILL HOUSEHOLDS WHILE CHILDREN UNDER THE AGE OF 18 ARE IN 16.9% OF HOUSEHOLDS. MISSION HILL IS HOME TO MORE THAN 20 HEALTH CARE, RESEARCH AND ACADEMIC INSTITUTIONS. MISSION HILL IS A SMALL BUT DIVERSE COMMUNITY. ALTHOUGH, HOME TO SOME OF THE CITY'S LARGEST EMPLOYERS AND SEVERAL HUNDRED MIDDLE AND UPPER INCOME RESIDENTS, MISSION HILL IS PRIMARILY A NEIGHBORHOOD OF LOWER-INCOME FAMILIES. SENIORS AND CHILDREN MAKE UP ROUGHLY 30% OF THE MISSION HILL POPULATION. TO LEARN ABOUT MEEI'S PATIENTS WHO RESIDE IN MISSION HILL, THE CONSULTANTS ANALYZED DATA FROM THE LARGER DATA SET FOR PATIENTS WHOSE ZIP CODE IS 02120 (THE ZIP CODE FOR MISSION HILL). DURING THE TIMEFRAME FROM WHICH PATIENT DATA WERE DRAWN, MEEI CARED FOR 263 PATIENTS WHO LIVE IN MISSION HILL (1.6% OF THE MISSION HILL POPULATION). WITH THE NEW FACILITY IN MISSION HILL AND A CONCENTRATED EFFORT TO PROVIDE SERVICES TO THE NEIGHBORHOOD THROUGH ITS COMMUNITY BENEFITS PROGRAMMING, WE EXPECT THAT NUMBER TO RISE OVER THE NEXT THREE YEARS. (SEE FIGURE 11 IN THE OFFICIAL MEEI COMMUNITY BENEFITS REPORT FOR THE DEMOGRAPHICS OF MEEI'S PATIENTS WHO LIVE IN MISSION HILL.) AFTER PROFILING THE DEMOGRAPHICS OF THE NEIGHBORHOOD, THE CONSULTANTS INTERVIEWED TWO SENIOR MANAGERS FOR COMMUNITY BENEFITS AT BRIGHAM AND WOMEN'S HOSPITAL (BWH). BWH IS LOCATED IN THE LONGWOOD MEDICAL AREA, NEIGHBORING MISSION HILL, AND HAS AN EXTENSIVE COMMUNITY BENEFITS PROGRAM THAT INVOLVES NUMEROUS INITIATIVES IN THE MISSION HILL. BOTH SENIOR MANAGERS HAVE SIGNIFICANT EXPERIENCE WORKING IN MISSION HILL AND WERE ABLE TO PROVIDE AN OVERVIEW OF BWH'S EXPERIENCE IN THE NEIGHBORHOOD. BOTH SENIOR MANAGERS SHARED A SYNOPSIS OF FINDINGS FROM THEIR OWN COMMUNITY BENEFITS NEEDS ASSESSMENT IN MISSION HILL. TO GAIN A BETTER UNDERSTANDING OF NEEDS IN MISSION HILL SPECIFICALLY, THE CONSULTANTS WORKED WITH THE MEEI CB WORKING GROUP AND WITH BRIGHAM AND WOMEN'S HOSPITAL COMMUNITY BENEFITS LEADERS TO IDENTIFY MISSION HILL SERVICE PROVIDERS, ADVOCATES AND EDUCATORS POSITIONED TO SPEAK TO THE NEEDS OF THE COMMUNITY. THE CONSULTANTS THEN CONDUCTED TEN IN-DEPTH INTERVIEWS WITH THE IDENTIFIED KEY INFORMANTS. AMONG THEM WAS A MEMBER OF THE NEW ENGLAND BAPTIST HOSPITAL, WHICH OPERATES A SMALLER BUT HIGHLY REGARDED COMMUNITY BENEFITS PROGRAM TARGETING MISSION HILL. THE EXPERIENCES OF THE BWH AND NEW ENGLAND BAPTIST PROVIDED GREAT INSIGHTS THAT INFORMED THE ASSESSMENT AND PLANNING PROCESSES DESCRIBED BELOW. THE INTERVIEWS YIELDED IMPORTANT AND USEFUL INFORMATION ABOUT NEIGHBORHOOD CHARACTERISTICS, METHODS FOR BUILDING AND SUSTAINING STRONG RELATIONSHIPS IN MISSION HILL, THE NEEDS OF THE NEIGHBORHOOD, AND PARTNERSHIP OPPORTUNITIES. THE INTERVIEW DATA WERE ANALYZED FOR COMMON AND DIVERGENT THEMES, WHICH ARE SUMMARIZED BELOW. MISSION HILL WAS DESCRIBED AS A COMMUNITY OF HIGH ECONOMIC NEED AND ONE IN WHICH JOB CREATION, JOB TRAINING, AND YOUTH EMPLOYMENT ARE HIGH PRIORITIES. THE KEY INFORMANTS DESCRIBED MISSION HILL RESIDENTS AS CULTURALLY AND LINGUISTICALLY DIVERSE WITH LARGE POPULATIONS OF HISPANIC, CHINESE, RUSSIAN, SOMALI, AND ETHIOPIAN RESIDENTS. THE COMMUNITY IS ALSO HOME TO A NUMBER OF HIGHLY DEDICATED ADVOCATES WHO ARE DEEPLY COMMITTED TO WORKING WITH INSTITUTIONAL NEIGHBORS TO BENEFIT THE NEIGHBORHOOD AND TO RESOLVE ISSUES AS THEY ARISE. MEEI IS VIEWED IN A POSITIVE LIGHT AND WAS OVERWHELMINGLY WELCOMED TO THE NEIGHBORHOOD. ALL OF THE KEY INFORMANTS EXPRESSED A SINCERE DESIRE TO HELP MEEI AS THE HOSPITAL BECOMES FAMILIAR WITH THE COMMUNITY AND INTRODUCES COMMUNITY BENEFITS PROGRAMS. |
| MISSION HILL RESIDENTS ACCESS ROUTINE HEALTH CARE SERVICES FROM MANY | SOURCES, INCLUDING THE LOCAL HOSPITAL PRIMARY CARE PRACTICES, COMMUNITY HEALTH CENTERS AND HOSPITAL EMERGENCY ROOMS. DIABETES WAS IDENTIFIED AS A PARTICULAR HEALTH ISSUE OF CONCERN IN MISSION HILL. THE KEY INFORMANTS REPORTED THAT VISION AND HEARING ISSUES ARE NOT ADDRESSED IN A COMPREHENSIVE MANNER IN THE COMMUNITY AND THAT A NEED FOR SUCH CARE EXISTS. THE KEYS TO BUILDING AND SUSTAINING STRONGLY RELATIONSHIPS IN THE COMMUNITY WERE DESCRIBED AS: -BEING A GOOD AND RESPECTFUL NEIGHBOR TO THOSE WHO ABUT THE NEW MEEI FACILITY, INCLUDING HAVING REGULAR DIALOGUE WITH THEM. -HAVING A PRESENCE IN MISSION HILL BY ATTENDING EVENTS. -HAVING A POINT PERSON/LIAISON TO THE NEIGHBORHOOD BEING RESPONSIVE AS NEEDS OR ISSUES ARISE -BEING INCLUSIVE, WORKING TO SERVE THE BROADER COMMUNITY RATHER THAN SPECIFIC ORGANIZATIONS WITHIN IT. -TAKING ADVANTAGE OF OPPORTUNITIES TO PARTNER WITH ORGANIZATIONS AND ADVOCATES IN MISSION HILL, INCLUDING MIKE ROSS, BOSTON CITY COUNCILMAN, WHO LIVES IN MISSION HILL. THE KEY INFORMANTS IDENTIFIED A NUMBER OF NEEDS THAT ARE CONSISTENT WITH MEEI'S CLINICAL EXPERTISE AND COMMUNITY BENEFITS MISSION, INCLUDING: -VISION/HEARING SCREENINGS FOR SENIORS AND FOR CHILDREN (TO COMPLEMENT SCREENINGS OFFERED BY THE BOSTON PUBLIC SCHOOLS) -FOLLOW UP CARE FOR SENIORS AND CHILDREN, INCLUDING FREE/REDUCED COST EYE GLASSES AND HEARING AIDS -EDUCATIONAL PROGRAMS/MATERIALS: -SENIORS: VISION CARE, ESPECIALLY RELATED TO DIABETES, BALANCE/FALLS PREVENTION, HEAD AND NECK ISSUES -YOUTH: HEARING ISSUES RELATED TO PORTABLE DEVICES AND HEADPHONES -TEACHERS: DETECTING HEARING AND VISION ISSUES AMONG STUDENTS AND THE RELATIONSHIP BETWEEN HEARING AND SPEECH. THE INTERVIEW PARTICIPANTS ALSO TALKED ABOUT THE NEED FOR ADDITIONAL JOB TRAINING/EMPLOYMENT OPPORTUNITIES, PARTICULARLY FOR YOUTH. SUGGESTIONS INCLUDED SUMMER JOBS FOR YOUTH, PAID INTERNSHIPS FOR YOUNG PEOPLE, EMPLOYMENT FOR MISSION HILL RESIDENTS AT THE MEEI MAIN CAMPUS AND THE MISSION HILL LOCATION, AND SCHOLARSHIP CONTRIBUTIONS. THE KEY INFORMANTS RECOMMENDED THAT MEEI "PIGGY BACK" ON EXISTING EFFORTS IN MISSION HILL TO REACH THE TARGET POPULATION FOR COMMUNITY BENEFITS INITIATIVES, GOING TO THE PLACE WHERE YOUTH AND SENIORS ALREADY TEND TO MEET (E.G., THE TOBIN COMMUNITY CENTER). THEY ALSO RECOMMENDED WORKING WITH ORGANIZATIONS THAT REPRESENT SENIORS AND CHILDREN FROM ACROSS MISSION HILL (E.G., THE LEGACY PROJECT, THE MISSION HILL YOUTH COLLABORATIVE) TO REACH THE MAXIMUM NUMBER OF YOUNG PEOPLE AND ELDERS IN THE COMMUNITY. THE ORGANIZATIONS IN MISSION HILL HAVE WELL-ESTABLISHED METHODS FOR COMMUNICATING WITH ONE ANOTHER AND WITH RESIDENTS ABOUT EVENTS IN THE COMMUNITY. ALTHOUGH SEVERAL USE EMAIL TO COMMUNICATE WITH THEIR COLLEAGUES IN OTHER ORGANIZATIONS, MOST ALSO DISSEMINATE FLYERS IN THE COMMUNITY TO ADVERTISE PROGRAMMING TO RESIDENTS. SOME ALSO USE PHONE TREES AND GO DOOR TO DOOR. NEWSLETTERS, CALENDARS, MONTHLY ORGANIZATION MEETINGS, AND THE LOCAL NEWSPAPER, THE MISSION HILL GAZETTE, ARE OTHER METHODS FOR SPREADING THE WORD IN MISSION HILL. ALL OF THE KEY INFORMANTS OFFERED TO HELP MEEI PUBLICIZE ITS COMMUNITY BENEFITS OFFERINGS THROUGH THEIR ESTABLISHED LINES OF COMMUNICATION. CONCLUSIONS: BASED ON THE FINDINGS FROM THE NEEDS ASSESSMENT IN MISSION HILL, THE COMMUNITY BENEFITS COMMITTEE DECIDED THAT IN EACH OF THE NEXT THREE YEARS, THE HOSPITAL'S COMMUNITY BENEFITS STRATEGIES IN THE NEIGHBORHOOD WILL INCLUDE THE FOLLOWING: -WORKING WITH THE MISSION HILL LEGACY PROJECT, OFFER A FREE VISION SCREENING TO AT LEAST 25 SENIORS AT ITS NEW LONGWOOD CENTER -WORKING WITH THE TOBIN COMMUNITY CENTER, PROVIDE A FREE EDUCATIONAL SESSION FOR YOUTH ON HEARING LOSS PREVENTION AT THE TOBIN COMMUNITY CENTER LOCATION. (IF IN YEARS 2 AND 3 OF THE PLAN, MEEI AND ITS COMMUNITY PARTNERS DETERMINE THAT SOMETHING DIFFERENT THAN THE ANNUAL VISION SCREENING FOR SENIORS OR HEARING EDUCATION EVENT FOR YOUTH IS NEEDED/PREFERABLE, THE PLAN WILL BE EDITED TO REFLECT SUCH CHANGES. THE OTHER COMMUNITY BENEFITS STRATEGIES ARE LIKELY TO OCCUR IN EACH OF THE THREE YEARS OF THE PLAN.) -WORKING WITH ONE OF THE EXISTING YOUTH EMPLOYMENT PARTNERS OR THE MISSION HILL YOUTH COLLABORATIVE, PROVIDE AN INTERNSHIP OPPORTUNITY TO A YOUNG PERSON IN MISSION HILL AT THE LONGWOOD FACILITY. -CONTINUE TO SUPPORT THE MISSION HILL MAIN STREET ROAD RACE (IN THE FORM OF AN ANNUAL $1000 SPONSORSHIP. -PARTICIPATE IN THE MISSION HILL HEALTH FAIR THAT IS HELD IN JUNE TO PROVIDE INFORMATION ON THE HOSPITAL AND PREVENTION AND TREATMENT OF CLINICAL ISSUES OF THE HEAD AND NECK. -ASSIST THOSE IN NEED OF FOLLOW UP CARE, INCLUDING HEARING AIDS AND GLASSES, TO OBTAIN COVERAGE FOR WHICH THEY ARE ELIGIBLE OR TO ACCESS ASSISTANCE THROUGH THE HOSPITAL (E.G., CHARITABLE CARE, FREE/REDUCE COST EYEGLASSES OR HEARING AID PROGRAMS). MEEI FILES AN ANNUAL COMMUNITY BENEFITS REPORT WITH THE MASSACHUSETTS ATTORNEY GENERAL. WHEN THE REPORTS ARE POSTED, THEY ARE AVAILABLE HERE: HTTP://WWW.MASSEYEANDEAR.ORG/ABOUT-US/OUTREACH/ |
| SCHEDULE H, PART VI, LINE 5: | MEEI'S COMMUNITY BENEFITS STRATEGIES FOR ACHIEVING ITS OBJECTIVES AND ANNUAL TARGETS PROGRAM FALL INTO FOUR MAJOR CATEGORIES: 1. SCREENING AND CLINICAL SERVICES 2. EDUCATION AND SUPPORT 3. ACCESS TO SERVICES/RESOURCES 4. SPONSORSHIPS CATEGORIES 1 AND 2 DRAW ON MEEI'S BROAD CLINICAL AND TEACHING EXPERTISE AND ENCOMPASS THE NEW JOB READINESS STRATEGIES. CATEGORY 3 RESPONDS TO BARRIERS AND OBSTACLES THAT LIMIT ACCESS TO SERVICES. CATEGORY 4 REPRESENTS MEEI'S OPPORTUNITY TO SUPPORT PARTNERS WHOSE MISSIONS ARE ALIGNED WITH THOSE OF MEEI AND WHO ARE PROVIDING SERVICES TO MEEI'S PRIORITY PATIENT GROUPS AND/OR GEOGRAPHIC AREAS. EACH CATEGORY BELOW OFFERS A DESCRIPTION OF THE ASSOCIATED STRATEGIES AND PARTNERSHIPS AND CONCLUDES WITH AN AT-A-GLANCE TABLE THAT DESCRIBES THE NUMBER OF INDIVIDUALS, TARGET AUDIENCE AND GEOGRAPHIC AREA SERVED, THE ATTORNEY GENERAL'S COMMUNITY BENEFITS CATEGORIES ADDRESSED, AND THE COSTS/RESOURCES EXPENDED FOR THE REPORTABLE YEAR FOR EACH STRATEGY IN THE CATEGORY. FISCAL YEAR 2014 WAS YEAR TWO OF MEEI'S THREE-YEAR PLAN. CATEGORY 1: SCREENING & CLINICAL SERVICES MEEI PROVIDES SCREENING AND CLINICAL SERVICES TO A WIDE RANGE OF INDIVIDUALS AND GROUPS, FROM LOW-INCOME CHILDREN TO SENIORS TO SURVIVORS OF DOMESTIC VIOLENCE. SPECIFIC INITIATIVES ARE AS DESCRIBED BELOW: NEIGHBORHOOD HOUSE CHARTER SCHOOL (NHCS) NHCS WAS FOUNDED IN 1995 TO PROVIDE A BETTER EDUCATIONAL OPTION FOR LOW-INCOME BOSTON FAMILIES AND TO INCUBATE INNOVATIVE PRACTICES THAT HAVE THE POTENTIAL TO IMPROVE PUBLIC EDUCATION FOR ALL STUDENTS. TODAY, NHCS SERVES 400 STUDENTS AND IS ONE OF THE MOST SOUGHT AFTER SCHOOLS IN THE CITY, SUCCESSFULLY SERVING A DIVERSE COMMUNITY OF CHILDREN IN GRADES PRE-K THROUGH 8 FROM DORCHESTER AND SURROUNDING BOSTON NEIGHBORHOODS. MEEI'S DEPARTMENTS OF AUDIOLOGY AND OPHTHALMOLOGY PARTNERED WITH NHCS'S SCHOOL NURSE TO OFFER VISION AND HEARING SCREENING TO ALL STUDENTS. CHILDREN WHO NEED FOLLOW-UP CARE RECEIVE IT, FREE IF NECESSARY, AT MEEI. WORKING WITH NHCS' SCHOOL NURSE, MARY MCNULTY-ANGLIN, WE SET A GOAL OF SCREENING ALL CHILDREN IN ADVANCE OF FLU SEASON TO MAXIMIZE THE NUMBER OF CHILDREN IN ATTENDANCE. |
| CAMP HARBOR VIEW: CREATED IN 2008 TO OFFER BOSTON CHILDREN A TRUE | SUMMER CAMP EXPERIENCE, CAMP HARBOR VIEW IS AN INITIATIVE OF THE NOT-FOR-PROFIT CAMP HARBOR VIEW FOUNDATION, INC. IN PARTNERSHIP WITH THE CITY OF BOSTON AND THE BOYS & GIRLS CLUBS OF BOSTON. THE CAMP OFFERS CHILDREN AGES 11 TO 14 LIVING IN BOSTON'S AT-RISK NEIGHBORHOODS THE OPPORTUNITY TO LEAVE THE CITY DURING THE DAY AND PARTICIPATE IN A FOUR-WEEK SUMMER CAMP PROGRAM. RECOGNIZING MEEI'S EXPERTISE IN VISION SCREENING, MAYOR MENINO REQUESTED THAT MEEI PLAY A ROLE AT CAMP HARBOR VIEW. MEEI HAS BEEN PARTNERING WITH THE CAMP SINCE ITS FIRST SEASON. MEEI STAFF MEMBERS TRAVELED TO CAMP HARBOR VIEW TO CONDUCT ON-SITE VISION SCREENINGS AND IDENTIFY THOSE IN NEED OF FOLLOW-UP CARE. VISION COALITION/YEAR UP BOSTON: THE MISSION OF VISION COALITION MASSACHUSETTS IS TO REMOVE POOR VISION AS AN IMPEDIMENT TO LITERACY, EDUCATION, AND A BETTER WAY OF LIFE. VISION COALITION PROVIDES FREE VISION SCREENINGS AND FREE EYEGLASSES. MEEI PARTNERS WITH VISION COALITION MASSACHUSETTS BY PERFORMING FULL EYE EXAMS AND PROVIDING MEDICAL CARE FOR PARTICIPANTS IN YEAR UP BOSTON, WHICH THE VISION COALITION IDENTIFIED THROUGH SCREENING AS NEEDING VISION CARE. YEAR UP SERVES YOUNG URBAN ADULTS, PROVIDING THEM WITH THE SKILLS, EXPERIENCE, AND SUPPORT THAT WILL EMPOWER THEM TO REACH THEIR POTENTIAL THROUGH PROFESSIONAL CAREERS AND HIGHER EDUCATION. MEEI STAFF MEMBERS GIVE EYE EXAMS TO THESE YOUNG ADULTS, PROVIDE THOSE WHO NEED THEM WITH EYE GLASSES (WHICH ARE PURCHASED AT COST BY VISION COALITION), AND ENSURE THAT THOSE WHO NEED FOLLOW-UP CARE ARE LINKED TO SERVICES. HEAD AND NECK CANCER SCREENING/LECTURE: MEEI'S DEPARTMENTS OF ENT AND SOCIAL WORK COLLABORATE TO OFFER CANCER SCREENING TO THE GENERAL PUBLIC AND TO PROVIDE SUPPORT FOR PEOPLE WITH ORAL, HEAD AND NECK CANCER. SUPPORT FOR PEOPLE WITH ORAL, HEAD AND NECK CANCER HAS A SUPPORT GROUP CHAPTER AT MASSACHUSETTS GENERAL HOSPITAL. MEEI COLLABORATES WITH THIS GROUP AND WITH THE HEAD AND NECK CANCER ALLIANCE TO RAISE AWARENESS DURING ORAL, HEAD AND NECK CANCER AWARENESS WEEK BY HOSTING AN EDUCATION TABLE. Face Forward Collaboration: The Face Forward program is a collaboration with Mass General Hospital formed after the collapse of the R.O.S.E. Fund (Regaining One's Self Esteem). The program continues the charter of breaking the silence and the cycle of domestic violence and teen dating violence and abuse. Face Forward screens and refers to Mass. Eye and Ear survivors of domestic violence in need of reconstructive surgery. Mass. Eye and Ear's surgeons perform these life-altering surgeries free of charge. The Legacy Project: The Legacy Project is a grassroots effort to provide support to seniors who reside in Mission Hill. Leaders of the Legacy Project reach out to seniors living in both public housing developments and to those who are living alone, providing information about services and community events. The Legacy Project also hosts a range of educational sessions and activities in its space at the Tobin Community Center. Activities range from computer classes to exercise and dance to intergenerational forums. The Legacy Project aims to build community through inclusiveness and communication, and partners with Mass. Eye and Ear in its community benefit programming for seniors. |
| CATEGORY 2: EDUCATION & SUPPORT | MEEI'S CLINICIANS AND SOCIAL WORKERS DELIVER EDUCATION AND SUPPORT TO INDIVIDUALS COPING WITH VARIOUS MEDICAL CONDITIONS OR CHALLENGES (E.G., SINUSITIS, HEARING LOSS, VISION LOSS, FACIAL PARALYSIS) AND ALSO REACH OUT TO PROVIDERS WHO INTERACT WITH SENIORS ACROSS THE COMMONWEALTH. DETAILS ON THESE EDUCATIONAL AND SUPPORT STRATEGIES ARE PRESENTED BELOW: PUBLIC FORUM ON HEARING AND HEARING LOSS: MEMBERS OF MEEI'S AUDIOLOGY DEPARTMENT PRESENTED AN 11TH ANNIVERSARY HAVE YOU HEARD? PUBLIC FORUM FEATURING EDUCATIONAL SESSIONS AND LECTURES ON HEARING AND HEARING LOSS. THIS YEAR'S SESSIONS FOCUSED ON THE MEDICAL AND SURGICAL MANAGEMENT OF HEARING LOSS, AUDIOLOGIC EVALUATION AND MANAGEMENT OF HEARING LOSS, AND SCIENTIFIC ADVANCES IN UNDERSTANDING HEARING AND HEARING LOSS. TARGETING THE GENERAL PUBLIC, AND ESPECIALLY SENIORS AND INDIVIDUALS WITH HEARING LOSS, THE EVENT WAS PUBLICIZED VIA COMMUNITY PAPERS AND THROUGH MEEI PARTNERSHIP WITH THE MASSACHUSETTS COUNCIL ON AGING. MEEI SURVEYS FORUM PARTICIPANTS AND WILL USE THEIR SUGGESTIONS TO DEVELOP THE EDUCATIONAL PROGRAM FOR NEXT YEAR. PUBLIC FORUM ON CONDITIONS THAT AFFECT SMELL AND TASTE: THIS YEAR, MEMBERS OF MEEI'S DEPARTMENT OF ENT OFFERED A SERIES OF LECTURES ON SINUSITIS. TARGETING THE GENERAL PUBLIC, AND ESPECIALLY SENIORS, THE EVENT WAS PUBLICIZED VIA COMMUNITY PAPERS AND VIA MEEI'S PARTNERSHIP WITH THE MASSACHUSETTS COMMISSION ON AGING. BOSTON CURED CANCER CLUB SUPPORT GROUP: THE BOSTON CURED CANCER GROUP FOR LARYNGECTOMEES SUPPORTS THE REHABILITATION OF LARYNGECTOMEES AND HELPS OFFER UNDERSTANDING TO PATIENTS AND THEIR LOVED ONES. MEEI HAS A STRONG COLLABORATIVE RELATIONSHIP WITH THIS ORGANIZATION, PROVIDING MEETING SPACE AND SPEAKERS FOR THE GROUPS. THE BOSTON CURED CANCER GROUP COMES AND MEETS WITH NEW LARYNGECTOMEES, PROVIDING SUPPORT TO MEEI PATIENTS. PARTICIPANTS IN THE GROUPS, MOSTLY OLDER PEOPLE, ARE LARGELY FROM METRO BOSTON, BUT SOME COME FROM GREATER DISTANCES. FACIAL PARALYSIS SUPPORT GROUP: THE FACIAL PARALYSIS SUPPORT GROUP IS A FORUM FOR INDIVIDUALS WITH FACIAL PARALYSIS AND THOSE CLOSE TO THEM TO MEET AND SHARE THEIR EXPERIENCES AND TO DISCUSS SUPPORT, TREATMENT, COPING AND SELF IMAGE. MEEI HOSTS THIS GROUP MONTHLY, PROVIDING MEETING SPACE AND SOCIAL WORK AND PHYSICIAN SUPPORT. WHILE THE GROUP IS OPEN TO ALL INDIVIDUALS WITH FACIAL PARALYSIS AND THEIR FAMILIES, PARTICIPANTS ARE GENERALLY FROM METRO BOSTON. MEEI PUBLICIZES THE SUPPORT GROUP VIA SOCIAL MEDIA AND THROUGH A PARTNERSHIP WITH THE FACIAL PARALYSIS SUPPORT NETWORK. HEAR @ BOSTON: HEAR@BOSTON, A CHAPTER OF THE HEARING LOSS ASSOCIATION OF AMERICA, IS A COMMUNITY ORGANIZATION THAT HELPS EMPOWER PEOPLE WHO HAVE HEARING LOSS BY FACILITATING OPPORTUNITIES FOR SOCIAL ENGAGEMENT, EDUCATION AND SKILL DEVELOPMENT. MEEI DONATES MONTHLY MEETING SPACE AND MEEI CLINICIANS SERVE AS SPEAKERS FOR MEETINGS AND EVENTS. MANY OF HEAR@BOSTON'S MEMBERS ARE YOUNG PROFESSIONALS BETWEEN THE AGES OF 20 AND 45, BUT THE GROUP ENCOURAGES PEOPLE OF ALL AGES TO JOIN. Mission Hill Community Health Fair: Mass. Eye and Ear, Longwood, was out in full force at the Mission Hill Community Health Fair, an annual wellness event. Mass. Eye and Ear provided safety tips for hearing and vision protection and learned about disease prevention. Mission Hill Women's Health Group: Mass. Eye and Ear provided a physician to give a talk and answer questions about eye health at a meeting of the Mission Hill Women's group. The intention of the talk was to provide information for healthier vision. THYROID EYE DISEASE SUPPORT GROUP: THE MASSACHUSETTS EYE AND EAR INFIRMARY OFFERS A THYROID EYE DISEASE (GRAVES' DISEASE) SUPPORT GROUP, WHICH WILL ALLOW MEMBERS TO EXPRESS THEIR CONCERNS ABOUT THIS CHRONIC ILLNESS TO HELP FORM A SOCIAL CONNECTION WITH OTHERS AND IMPROVE COPING SKILLS. THE OPEN FORUM GIVES MEMBERS THE OPPORTUNITY TO EXCHANGE INFORMATION ABOUT GRAVES' DISEASE AND GIVES PHYSICIAN SPEAKERS A CHANCE TO INFORM MEMBERS OF THE LATEST TREATMENTS. MEEI DONATES MEETING SPACE FOR THIS GROUP, WHICH MEETS QUARTERLY. VISION REHABILITATION: IN THE AREA OF VISION REHABILITATION EDUCATION, MEEI STAFF RESPONDED TO A NUMBER OF REQUESTS FROM ORGANIZATIONS SERVING SENIORS TO PROVIDE SUPPORTIVE EDUCATION RELATED TO VISION REHABILITATION. DRESS FOR SUCCESS: THE MISSION OF DRESS FOR SUCCESS BOSTON IS TO PROMOTE THE ECONOMIC INDEPENDENCE OF DISADVANTAGED WOMEN. THEY DO THIS BY PROVIDING PROFESSIONAL ATTIRE, A NETWORK OF SUPPORT AND THE CAREER DEVELOPMENT TOOLS TO HELP WOMEN THRIVE IN WORK AND IN LIFE. MEEI MAKES AN ANNUAL DONATION TO THIS ORGANIZATION TO HELP ADVANCE ITS EFFORTS IN WORKFORCE DEVELOPMENT AMONG LOW-INCOME WOMEN. Internships/Coops: Mass. Eye and Ear provides internships and coops to help get young people interested in health care so they can better care for their communities. This program introduces students to the wide variety of careers in healthcare, helps them see how various hospital roles are intertwined, and gives them opportunities to broaden the circle of role models in their lives. Partners include the PIC program, John Hancock, YMCA Training, Inc, Northeastern University. The Tobin Community Center: The Tobin Community Center is one of 35 Boston Center for Youth and Families facilities which are located in every neighborhood in Boston. The Center provides recreational space and activities for youth and families, including basketball courts, workout space, a daycare facility, career learning center and a diverse range of programs and activities for all interests. The mission of BCYF is to enhance the quality of life for Boston's residents by supporting children, youth and families through a wide range of programs and services. The Center hosts Mass. Eye and Ear educational sessions. Mission Hill Youth Collaborative: The Mission Hill Youth Collaborative is a grassroots coalition of community-based organizations and institutions that promotes the well-being of the neighborhood's young people and their families through collaborative activities. MHYC brings together youth-serving organizations and institutions to address the needs of the community in light of changing economic and social conditions as well as institutional expansion. The members have advocated for more effective programming, improved resources, and built a support network for the Mission Hill youth workers, youth, and their families. John Hancock MLK Summer Scholars: The MLK Summer Scholars program addresses a critical need in the City of Boston - summer jobs for youth. Mass. Eye and Ear hires young people each summer. In additional to the experience gained on the job, interns get additional support through participation in weekly job readiness and life skills workshops. Mass. Eye and Ear provides a summer job to one MLK Scholar each summer. Boston Private Industry Council (PIC): The PIC is a public-private partnership that connects business, schools, government, labor, and community organizations to create innovative workforce solutions. PIC helps businesses develop the workforce they need and Boston residents gain access to career opportunities and higher incomes. The PIC connects youth and adults with education and employment opportunities. Mass. Eye and Ear hires 12 PIC students as summer interns. CATEGORY 3: ACCESS TO SERVICES/RESOURCES THIS CATEGORY DESCRIBES MEEI STRATEGIES TO MAKE SERVICES AND RESOURCES AVAILABLE TO INDIVIDUALS WHO MIGHT NOT OTHERWISE BE ABLE TO ACCESS THEM. THESE SERVICES AND RESOURCES ARE AS FOLLOWS: |
| TRANSPORTATION FOR NEEDY PATIENTS: MEEI PROVIDES FREE TAXI | TRANSPORTATION FOR PATIENTS AND FAMILIES IN EMERGENCY SITUATIONS. FREE EYEGLASSES PROGRAM: SOCIAL WORK STAFF, PATIENT FINANCIAL COUNSELORS, AND OPTICAL SHOP STAFF COLLABORATE TO PROVIDE FREE GLASSES TO MEEI PATIENTS WHO MEET INCOME AND OTHER ELIGIBILITY GUIDELINES AND ARE UNABLE TO PAY FOR GLASSES. CONSULTATION FOR NON-MEEI PATIENTS: MEEI'S SOCIAL WORK STAFF PROVIDES INFORMATION AND REFERRAL FOR FINANCIAL RESOURCES, VISION AND HEARING RESOURCES, HOMECARE, AND EDUCATION TO NON-MEEI PATIENTS. SOCIAL WORK CONSULTATIONS FOR PATIENTS NEEDING FINANCIAL ASSISTANCE: THE STAFF FROM MEEI'S DEPARTMENT OF SOCIAL WORK ASSISTS PATIENTS IN SECURING LODGING, MEAL VOUCHERS, PARKING VOUCHERS, AND OTHER SMALL NECESSITIES THAT MAKE IT POSSIBLE FOR PATIENTS AND FAMILIES TO RECEIVE TREATMENT AT MEEI. FINANCIAL COUNSELING ASSISTANCE: THE HOSPITAL'S FINANCIAL COUNSELORS WORK WITH PATIENTS TO ASSESS INSURANCE COVERAGE, IDENTIFY COVERAGE OPTIONS FOR WHICH THE UN/UNDER-INSURED MAY BE ELIGIBLE, AND TO PROVIDE ASSISTANCE IN APPLYING FOR AND ACCESSING COVERAGE. HOWE LIBRARY: MEEI'S RESEARCH LIBRARY STAFF ASSISTS PATIENTS WHO ARE SEEKING INFORMATION ABOUT THEIR MEDICAL CONDITIONS. SERVICES INCLUDE COMPUTER SEARCHING AND RETRIEVAL OF ARTICLES, FINDING BOOKS FOR USERS, AND PROVIDING COMPUTERS, COPIERS, PRINTERS, AND ASSISTANCE TO PEOPLE IN USING THEM. THE HEARING AID CENTER: THE MEEI HEARING AID CENTER PROVIDES SUPPORT, INCLUDING EDUCATION AND EQUIPMENT, TO PATIENTS WITH HEARING LOSS. FOR PATIENTS WHO MEET INCOME GUIDELINES, THESE SERVICES ARE PROVIDED AT NO CHARGE OR AT A REDUCED RATE. FREE PARKING: MEEI OFFERS FREE PARKING TO PATIENTS AND THEIR FAMILIES THAT ENABLES THEM TO COME FOR CARE AND PARTICIPATE IN SUPPORT GROUPS. MEEI ALSO EXTENDS FREE PARKING TO PARTICIPANTS AT COMMUNITY BOATING, A LOCAL NONPROFIT, AND TO SUPPORT GROUPS SUCH AS THE GLAUCOMA SUPPORT GROUP AND HEAR @ BOSTON. CHARITABLE CARE: EACH YEAR, MEEI PROVIDES FREE OR DISCOUNTED CARE TO PATIENTS WHO ARE UNABLE TO COVER THE FULL COST OF THE SERVICES THEY UTILIZE. THIS YEAR THE HOSPITAL PROVIDED $194,886 IN FREE OR DISCOUNTED CARE TO PATIENTS THAT MEET MEEI'S FINANCIAL ASSISTANCE POLICY. MEEI MAKES EVERY EFFORT TO IDENTIFY APPROPRIATE INSURANCE COVERAGE FOR PATIENTS AND TO HELP THEM ACCESS THE COVERAGE FOR WHICH THEY ARE ELIGIBLE. HOWEVER, EACH YEAR MEEI PROVIDES CARE TO PATIENTS THAT IS NOT FULLY REIMBURSED. IN 2014, MEEI'S NET CHAIRTY CARE TOTALLED $2,719,571, WHICH INCLUDES THE HEALTH SAFETY NET (HSN) ASSESSMENT AND SHORTFALL, HSN DENIED CLAIMS, AND FREE OR DISCOUNTED CARE PROVIDED TO PATIENTS THAT MEET MEEI'S FINANCIAL ASSISTANCE POLICY. THE NET CHARITY CARE PROVIDED EACH YEAR IS A REFLECTION OF MEEI'S AND THE COMMUNITY BENEFITS COMMITTEE'S COMMITMENT TO THE DELIVERY OF HIGH-QUALITY CARE TO PATIENTS AND IS AN IMPORTANT STRATEGY FOR ENSURING ACCESS TO CARE IN THE MEEI COMMUNITY BENEFITS PLAN. CATEGORY 4: SPONSORSHIPS MEEI DESIGNATES A PORTION OF ITS COMMUNITY BENEFITS RESOURCES TO PROVIDE FINANCIAL SUPPORT IN THE FORM OF SPONSORSHIPS TO A SELECT NUMBER OF ORGANIZATIONS WHOSE MISSIONS ALIGN WITH THOSE OF MEEI AND ITS COMMUNITY BENEFITS GOALS, INCLUDING THOSE WHO ADDRESS ISSUES AFFECTED THE TARGET COMMUNITIES AND POPULATIONS OF THE HOSPITAL'S COMMUNITY BENEFIT PLAN. EACH OF THESE ORGANIZATIONS PROMOTES WELLNESS AMONG THEIR TARGET POPULATION AND SERVES PEOPLE FROM ACROSS THE COMMONWEALTH. SCHEDULE H, PART VI, LINE 6: NOT APPLICABLE |
| SCHEDULE H, PART VI, LINE 7: | LIST OF STATES RECEIVING COMMUNITY BENEFIT REPORT: MA |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (true) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (26 entries)
| Address Line1USAddress/AddressLine1 | CityUSAddress/City | StateUSAddress/State | ZIP CodeUSAddress/ZIPCode | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Purpose Of GrantPurposeOfGrantTxt |
|---|---|---|---|---|---|---|---|
| BOSTON CHILDREN'S HOSPITAL | |||||||
| 300 LONGWOOD AVE | BOSTON | MA | 02115 | 042774441 | 501(C)(3) | $147,876 | RESEARCH |
| BOSTON UNIVERSITY | |||||||
| 85 E NEWTON ST M-921 | BOSTON | MA | 02118 | 042103547 | 501(C)(3) | $60,551 | RESEARCH |
| BRIGHAM AND WOMEN'S HOSPITAL | |||||||
| 75 FRANCIS ST | BOSTON | MA | 02115 | 042312909 | 501(C)(3) | $247,340 | RESEARCH |
| OHIO UNIVERSITY | |||||||
| 1 PARK PLACE | ATHENS | OH | 45701 | 316402113 | 501(C)(3) | $49,618 | RESEARCH |
| JOHNS HOPKINS UNIVERSITY | |||||||
| 600 N WOLF ST | BALTIMORE | MD | 21218 | 520595110 | 501(C)(3) | $10,496 | RESEARCH |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||
| 55 FRUIT ST | BOSTON | MA | 02114 | 042697983 | 501(C)(3) | $577,841 | RESEARCH |
| MIT DIVISION OF HEALTH | |||||||
| 77 MASS AVE | CAMBRIDGE | MA | 02139 | 042103594 | 501(C)(3) | $84,724 | RESEARCH |
| MAYO CLINIC | |||||||
| 200 1ST ST SW | ROCHESTER | MN | 55905 | 416011702 | 501(C)(3) | $121,084 | RESEARCH |
| HARVARD UNIVERSITY | |||||||
| MASS HALL | CAMBRIDGE | MA | 02138 | 042103580 | 501(C)(3) | $1,041,998 | RESEARCH |
| VANDERBILT MEDICAL CENTER | |||||||
| 211 KIRKLAND HALL | NASHVILLE | TN | 37240 | 620476822 | 501(C)(3) | $25,111 | RESEARCH |
| WORCESTER POLYTECHNIC INSTITUTE | |||||||
| 100 INSTITUTE RD | WORCESTER | MA | 01609 | 042121659 | 501(C)(3) | $124,482 | RESEARCH |
| SCHEPENS EYE RESEARCH INSTITUTE | |||||||
| 20 STANIFORD ST | BOSTON | MA | 02114 | 042129889 | 501(C)(3) | $1,216,859 | RESEARCH |
| UNIVERSITY OF MIAMI | |||||||
| 1400 NW 10TH AVE | MIAMI | FL | 33136 | 590624458 | 501(C)(3) | $156,552 | RESEARCH |
| BROAD INSTITUTE | |||||||
| 7 CAMBRIDGE CENTER | CAMBRIDGE | MA | 02142 | 263428781 | 501(C)(3) | $8,389 | RESEARCH |
| MEDICAL COLLEGE OF WISCONSIN | |||||||
| 8701 WATERTOWN PLANK RD | MILWAUKEE | WI | 53226 | 390806261 | 501(C)(3) | $49,196 | RESEARCH |
| DREXEL UNIVERSITY | |||||||
| 3201 ARCH ST 100 | PHILADELPHIA | PA | 19104 | 231352630 | 501(C)(3) | $25,176 | RESEARCH |
| TUFTS UNIVERSITY | |||||||
| 136 HARRISON AVE | BOSTON | MA | 02111 | 042163634 | 501(C)(3) | $9,632 | RESEARCH |
| MASSACHUSETTS EYE AND EAR ASSOCIATES INC | |||||||
| 243 CHARLES STREET | BOSTON | MA | 02114 | 222658209 | 501(C)(3) | $12,247,673 | INSTITUTIONAL |
| RHODE ISLAND HOSPITAL | |||||||
| 593 Eddy Street | Providence | RI | 029034923 | 050258954 | 501(c)(3) | $344,385 | RESEARCH |
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SD | |||||||
| 9500 Gilman Dr MC0934 | San Diego | CA | 92023 | 956006144 | 115 | $28,618 | RESEARCH |
| JOAN&SANFORD IWEILL MEDICAL COLL OF CORNEL UNIV | |||||||
| 1305 New York Ave | New York | NY | 10065 | 150532082 | 501(c)(3) | $83,301 | RESEARCH |
| MARSHFIELD CLINICAL RESEARCH FOUNDATION | |||||||
| 1000 North Oak Avenue | Marshfield | WI | 54449 | 390452970 | 501(c)(3) | $7,932 | RESEARCH |
| SCHEPENS EYE RESEARCH INSTITUTE | |||||||
| 20 STANIFORD ST | BOSTON | MA | 02114 | 042129889 | 501(C)(3) | $841,628 | INSTITUTIONAL |
| Chicago Association for Research and Education | |||||||
| 5000 South 5th Avenue | Hines | IL | 60141 | 363334177 | 501(C)(3) | $161,402 | RESEARCH |
| Loyola University of Chicago | |||||||
| 2160 S First Ave | Maywood | IL | 60153 | 361408475 | 501(C)(3) | $13,613 | RESEARCH |
| University of Michigan | |||||||
| 500 S State St | Ann Arbor | MI | 48109 | 386006309 | 115 | $18,023 | RESEARCH |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 25 | Total501c3OrgCnt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | SCHEDULE I, PART I, LINE 2: | FormAndLineReferenceDesc |
| Explanation | SUBRECIPIENT MONITORING POLICY AND PROCEDURES Part I. Subawards are issued through a consortium agreement between the Massachusetts Eye and Ear Infirmary ("MEEI") and the recipient institution. The agreement specifies the terms of the subaward, and includes a detailed budget and scope of work to be performed by the recipient institution. Awarded funds are encumbered by a purchase order that is assigned to a unique fund number. Payments to recipient institutions made against the purchase order are recorded in the MEEI accounting system so that individual payments and purchase order balances can be monitored. Disbursement of funds for subawards require the written approval of the Principal Investigator("PI"). Frequent progress reports and other forms of communication are required between the PI and the subrecipient institute to ensure that the scope of work is progressing at a satisfactory pace. Research Administration also conducts an annual inventory of institutions to which research has been sub awarded. A risk assessment matrix is employed, along with a review of the subrecepients most recent A133 audit report, to determine the level of risk regarding the sub recipient's ability to comply with federal guidelines. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Independent Consultant | Yes (X) | IndependentConsultantInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | Yes (true) | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | Yes (true) | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | false | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | false | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | false | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | false | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | false | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | Yes (true) | AnyNonFixedPaymentsInd |
| Initial Contract Exception | false | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (19 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JOHN R FERNANDEZ | ||||||||||||||
| PRESIDENT | $694,419 | $0 | $98,240 | $0 | $810 | $0 | $184,446 | $0 | $23,217 | $0 | $1,001,132 | $0 | $0 | $0 |
| JOAN W MILLER MD | ||||||||||||||
| DIRECTOR | $0 | $672,191 | $0 | $73,339 | $0 | $19,822 | $0 | $35,115 | $0 | $23,610 | $0 | $824,077 | $0 | $0 |
| JOSEPH B NADOL JR MD | ||||||||||||||
| DIRECTOR (until 2/28/2014) | $0 | $705,204 | $0 | $36,150 | $0 | $32,190 | $0 | $35,115 | $0 | $23,731 | $0 | $832,390 | $0 | $0 |
| SUSAN WILLIAMS | ||||||||||||||
| ASST SEC/GC (UNTIL 8/7/13) | $116,502 | $0 | $0 | $0 | $112,795 | $0 | $3,015 | $0 | $5,940 | $0 | $238,252 | $0 | $0 | $0 |
| MAUREEN KELLEY | ||||||||||||||
| ASST SECRETARY | $179,931 | $0 | $4,500 | $0 | $389 | $0 | $7,773 | $0 | $22,455 | $0 | $215,048 | $0 | $0 | $0 |
| CAROLANN WILLIAMS | ||||||||||||||
| CFO & VP FINANCE AND ADMIN | $330,066 | $0 | $36,193 | $0 | $509 | $0 | $10,081 | $0 | $1,634 | $0 | $378,483 | $0 | $0 | $0 |
| BARBARA J SCULLY | ||||||||||||||
| DIRECTOR PROF REV CYCLE | $175,749 | $0 | $5,000 | $0 | $219 | $0 | $13,970 | $0 | $22,351 | $0 | $217,289 | $0 | $0 | $0 |
| EILEEN O LOWELL | ||||||||||||||
| CNO & VP PAT CARE SVS | $233,862 | $0 | $20,173 | $0 | $977 | $0 | $15,226 | $0 | $22,688 | $0 | $292,926 | $0 | $0 | $0 |
| ALAN K LONG | ||||||||||||||
| VP RESEARCH ADMINISTRATION | $190,360 | $0 | $18,727 | $0 | $18,754 | $0 | $8,592 | $0 | $1,034 | $0 | $237,467 | $0 | $0 | $0 |
| CHRISTINE REGAN | ||||||||||||||
| VP HUMAN RSRCS (until 8/9/13) | $131,293 | $0 | $0 | $0 | $137,002 | $0 | $3,451 | $0 | $7,201 | $0 | $278,947 | $0 | $0 | $0 |
| KENNETH HOLMES | ||||||||||||||
| CFO MEEA | $230,478 | $65,904 | $18,385 | $16,044 | $22,840 | $353,651 | ||||||||
| JEAN E MACQUIDDY | ||||||||||||||
| VP OTOLARYNGOLOGY(UNTIL3/1/14) | $236,808 | $0 | $7,226 | $0 | $3,685 | $0 | $26,610 | $0 | $8,676 | $0 | $283,005 | $0 | $0 | $0 |
| JEFFREY J PIKE | ||||||||||||||
| CHIEF OPERATING OFFICER | $302,207 | $0 | $25,731 | $0 | $487 | $0 | $12,408 | $0 | $9,067 | $0 | $349,900 | $0 | $0 | $0 |
| JAVIER BALLOFFET | ||||||||||||||
| VP OPHTHALMOLOGY(until 5/2/14) | $235,087 | $0 | $0 | $0 | $20,476 | $0 | $15,952 | $0 | $22,874 | $0 | $294,389 | $0 | $0 | $0 |
| JENNIFER STREET | ||||||||||||||
| VP COMMUNICATIONS & PLANNING | $297,197 | $0 | $25,840 | $0 | $736 | $0 | $12,781 | $0 | $23,137 | $0 | $359,691 | $0 | $0 | $0 |
| MELISSA M PAUL | ||||||||||||||
| CHIEF DEVELOPMENT OFFICER | $195,731 | $0 | $19,903 | $0 | $18,011 | $0 | $15,696 | $0 | $22,728 | $0 | $272,069 | $0 | $0 | $0 |
| PHILLIP C JOHNSON | ||||||||||||||
| DIR FINANCIAL OPERATIONS | $161,206 | $0 | $9,000 | $0 | $18,197 | $0 | $20,593 | $0 | $22,773 | $0 | $231,769 | $0 | $0 | $0 |
| RALPH T PELOSI | ||||||||||||||
| DIRECTOR FACILITIES PLANNING | $167,670 | $0 | $10,000 | $0 | $922 | $0 | $8,258 | $0 | $916 | $0 | $187,766 | $0 | ||
| MICHAEL RICCI | ||||||||||||||
| CHIEF INFORMATION OFFICER | $216,788 | $10,000 | $210 | $8,886 | $22,738 | $258,622 | ||||||||
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | SCHEDULE J, PART I, LINE 4A: | FormAndLineReferenceDesc |
| Explanation | In connection with her departure effective August 7, 2013, Susan Williams received 6 months of salary continuation. Amounts paid under this agreement in 2013 of $83,393 are included in part ii, column b(iii). In connection with her departure effective August 9, 2013, Christine Regan received a lump sum payment of $111,602 of severence representing 6 months of salary and a $2,500 payment. Amounts paid under this agreement in 2013 are included in part ii, column b(iii). SCHEDULE J, PART I, LINE 4B: John Fernandez participates in a Deferred Compensation arrangement with Massachusetts Eye and Ear. Under the agreement, Mr. Fernandez will be credited $150,000 for CALENDAR YEAR 2013. Each annual credit will vest on the fourth anniversary of the date such credit was made or upon (1) the attainment of the age of 65 while employed; (2) termination without cause or resignation for good reason; (3) death; (4) disability; or (5) change of control of MASSACHUSETTS Eye and Ear within the meaning of section 409A of the Internal Revenue Code. SCHEDULE J, PART I, LINE 7: The Board of Trustees of the Massachusetts Eye and Ear Infirmary, upon recommendations of the Compensation Committee, approve a bonus program for certain individuals listed on the Schedule J. The program requires that supervisory personnel make the determination of (1) eligibility and (2) amount of bonus dollars based on overall job performance. The CEO of the Infirmary has the authority to (1) overrule recommendations made by supervisors and (2) make bonus determinations for Vice President level personnel. The Compensation Committee of the board has the final authority for bonuses paid to the CEO as well as the Vice Presidents. Total Compensation for listed individuals, including bonus payments, was analyzed by independent compensation consultants, determined to be reasonable compensation, and approved by the Board. No compensation payment can be made in excess of these amounts. | ExplanationTxt |
Schedule K IRS990ScheduleK
Tax Exempt Bonds Issues TaxExemptBondsIssuesGrp (3 entries)
| Bond ReferenceBondReferenceCd | Bond Issuer EINBondIssuerEIN | CUSIPCUSIPNum | Bond IssuedBondIssuedDt | Issue PriceIssuePriceAmt | PurposePurposeDesc | DefeasedDefeasedInd | On Behalf Of IssuerOnBehalfOfIssuerInd | Pool FinancingPoolFinancingInd |
|---|---|---|---|---|---|---|---|---|
| MASSACHUSETTS HEALTH AND EDUCATIONAL FACILITIES | ||||||||
| A | 042456011 | 57586EWL1 | 2010-09-29 | $63,156,092 | FACILITY IMPROVEMENTS | false | false | false |
| MASSACHUSETTS HEALTH AND EDUCATIONAL FACILITIES | ||||||||
| B | 042456011 | 57586ELD1 | 2007-03-22 | $20,000,000 | FACILITY IMPROVEMENTS | false | false | Yes (true) |
| MASSACHUSETTS HEALTH AND EDUCATIONAL FACILITIES | ||||||||
| C | 042456011 | 57586ELD1 | 2005-02-25 | $13,695,000 | FACILITY IMPROVEMENTS | false | false | Yes (true) |
Tax Exempt Bonds Proceeds TaxExemptBondsProceedsGrp (3 entries)
| Bond ReferenceBondReferenceCd | RetiredRetiredAmt | Bond DefeasedBondDefeasedAmt | Total ProceedsTotalProceedsAmt | In Reserve FundInReserveFundAmt | Capitalized InterestCapitalizedInterestAmt | Refunding EscrowRefundingEscrowAmt | Issuance Costs From ProceedsIssuanceCostsFromProceedsAmt | Credit EnhancementCreditEnhancementAmt | Working Capital ExpendituresWorkingCapitalExpendituresAmt | Capital ExpendituresCapitalExpendituresAmt | Other Spent ProceedsOtherSpentProceedsAmt | UnspentUnspentAmt | Current RefundingCurrentRefundingInd | Advance RefundingAdvanceRefundingInd | Final Allocation MadeFinalAllocationMadeInd | Adequate Books And Rec MaintAdequateBooksAndRecMaintInd | Substantial CompletionSubstantialCompletionYr |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | $1,620,000 | $0 | $63,156,092 | $5,013,431 | $5,191,181 | $0 | $1,243,623 | $0 | $0 | $48,036,561 | $0 | $3,671,296 | false | false | false | Yes (true) | |
| B | $9,138,000 | $0 | $20,000,000 | $106,620 | $0 | $0 | $100,000 | $0 | $0 | $19,700,000 | $93,380 | $0 | false | false | Yes (true) | Yes (true) | 2010 |
| C | $6,693,592 | $0 | $13,695,000 | $68,647 | $0 | $0 | $68,475 | $0 | $0 | $13,489,575 | $68,300 | $0 | false | false | Yes (true) | Yes (true) | 2009 |
Tax Exempt Bonds Private Bus Use TaxExemptBondsPrivateBusUseGrp (3 entries)
| Bond ReferenceBondReferenceCd | Owning Bond Financed PropertyOwningBondFinancedPropertyInd | Any Lease ArrangementsAnyLeaseArrangementsInd | Mgmt Contract Bond Fincd PropMgmtContractBondFincdPropInd | Any Research AgreementsAnyResearchAgreementsInd | Private Bus Use By OthersPrivateBusUseByOthersPct | Bond Iss Meet Prvt Sec Pymt TestBondIssMeetPrvtSecPymtTestInd | Procs Nonqualified Bond RemdtdProcsNonqualifiedBondRemdtdInd |
|---|---|---|---|---|---|---|---|
| A | false | false | false | false | 0 | false | Yes (true) |
| B | false | false | false | false | 0 | false | Yes (true) |
| C | false | false | false | false | 0 | false | Yes (true) |
Tax Exempt Bonds Arbitrage TaxExemptBondsArbitrageGrp (3 entries)
| Bond ReferenceBondReferenceCd | Form8038 T FiledForm8038TFiledInd | Rebate Not Due YetRebateNotDueYetInd | Variable Rate IssueVariableRateIssueInd | Hedge Identified In Bks And RecHedgeIdentifiedInBksAndRecInd | Gross Proceeds Invested In GICGrossProceedsInvestedInGICInd | Business Name Line1GICProviderName/BusinessNameLine1 | Gross Proceeds InvestedGrossProceedsInvestedInd | Written Proc To Monitor ReqsWrittenProcToMonitorReqsInd |
|---|---|---|---|---|---|---|---|---|
| 0 | ||||||||
| A | false | Yes (true) | false | false | false | 0 | false | false |
| 0 | ||||||||
| B | Yes (true) | Yes (true) | false | false | 0 | false | false | |
| 0 | ||||||||
| C | Yes (true) | Yes (true) | false | false | 0 | false | false | |
Procedures Corrective Action ProceduresCorrectiveActionGrp (3 entries)
| Bond ReferenceBondReferenceCd | Procedures Corrective ActionProceduresCorrectiveActionInd |
|---|---|
| A | Yes (true) |
| B | Yes (true) |
| C | Yes (true) |
Supplemental Information Detail SupplementalInformationDetail (3 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART I, BOND (A), COLUMN (F): | THE PROJECT CONSISTS OF RENOVATION AND IMPROVEMENT OF EXISTING SPACE AND ACQUISITION OF MISCELLANEOUS EQUIPMENT LOCATED IN MEEI'S MAIN CLINICAL BUILDING, INCLUDING BUT NOT LIMITED TO THE FOLLOWING: THE AMBULATORY AND INPATIENT OPERATING ROOMS, THE SINUS CLINIC, THE NEURO-OPTHALMOLOGY CLINIC, THE OTOLARYNGOLOGY LASER CENTER, THE ENT CLINIC FOCUSING ON HEAD AND NECK CONDITIONS, THE PRE-ADMISSION TESTING SUITE, THE OPHTHALMOLOGY OUTPATIENT CLINICS LOCATED ON THE FIRST FLOOR, THE GROUND FLOOR (INCLUDING THE LOBBY AREA, EMERGENCY DEPARTMENT AND RADIOLOGY DEPARTMENT), THE PEDIATRIC OPHTHALMOLOGY CLINIC, THE HEAD AND NECK CLINIC, THE LASER CENTER, THE PEDIATRIC INPATIENT UNIT, THE OPHTHALMOLOGY PLASTICS OUTPATIENT CLINIC, THE OTOLARYNGOLOGY FACULTY OFFICE SUITE AND THE DESIGN AND ARCHITECTURAL FEES RELATING TO THE RECONSTRUCTING OF THE GROUND, FIRST, SECOND AND THIRD FLOORS FOR ADDITIONAL CLINICAL SPACE. IMPROVEMENTS TO EXISTING BUILDING INFRASTRUCTURE. PLANNING AND DESIGN COSTS RELATED TO A REPLACEMENT RESEARCH OR CLINICAL BUILDING TO BE LOCATED AT 309-325 CAMBRIDGE STREET. COSTS OF ISSUANCE AND CAPITALIZED INTEREST ON THE BONDS FINANCING THE PROJECTS DESCRIBED IN THIS SECTION FOR A PERIOD OF UP TO THREE YEARS. |
| PART I, BOND (B), COLUMN (F): | THE PROJECT ALL TO BE OWNED AND OPERATED BY THE INFIRMARY, CONSISTS GENERALLY OF (A) RENOVATION OF THE OUTPATIENT AREAS OF THE INFIRMARY AND OF THE 7TH FLOOR SERVICE AREA AND OFFICES, ALL LOCATED AT 243 CHARLES STREET, BOSTON, MASSACHUSETTS, AND (B) EQUIPMENT PURCHASES. |
| PART I, BOND (C), COLUMN (F): | THE PROJECT ALL TO BE OWNED AND OPERATED BY THE INFIRMARY, CONSISTS GENERALLY OF (A) RENOVATION OF THE OUTPATIENT AREAS OF THE INFIRMARY AND OF THE 7TH FLOOR SERVICE AREA AND OFFICES, ALL LOCATED AT 243 CHARLES STREET, BOSTON, MASSACHUSETTS, AND (B) EQUIPMENT PURCHASES. |
Schedule L IRS990ScheduleL
Loans Btwn Org Interested Prsn LoansBtwnOrgInterestedPrsnGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | KENNETH HOLMES | PersonNm |
| Relationship With Org | KEY EMPLOYEE | RelationshipWithOrgTxt |
| Loan Purpose | HOUSING | LoanPurposeTxt |
| Loan From Organization | Yes (X) | LoanFromOrganizationInd |
| Original Principal | $50,000 | OriginalPrincipalAmt |
| Balance Due | $10,000 | BalanceDueAmt |
| Default | false | DefaultInd |
| Board Or Committee Approval | false | BoardOrCommitteeApprovalInd |
| Written Agreement | Yes (true) | WrittenAgreementInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Balance Due | $10,000 | TotalBalanceDueAmt |
Bus Tr Involve Interested Prsn BusTrInvolveInterestedPrsnGrp
Name Of Interested NameOfInterested
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | JOAN MILLER MD | PersonNm |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Relationship Description | DRCTR IS LICENSOR TO ORG | RelationshipDescriptionTxt |
| Transaction | $177,331 | TransactionAmt |
| Transaction | PATENT LICENSE PROCEEDS | TransactionDesc |
| Sharing Of Revenues | false | SharingOfRevenuesInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | SCHEDULE L, PART V, BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS | FormAndLineReferenceDesc |
| Explanation | (A) NAME OF PERSON: JOAN MILLER, MD (D) DESCRIPTION OF TRANSACTION: INVENTOR PROCEEDS FOR PATENT RIGHTS ARE MADE IN ACCORDANCE WITH WRITTEN MEEI POLICY IN RESPECT OF INTELLECTUAL PROPERTY. | ExplanationTxt |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (16 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, PART I, LINE 1 & PART III, LINE 1: | THE MASSACHUSETTS EYE AND EAR INFIRMARY ("THE INFIRMARY") IS A NOT-FOR-PROFIT TEACHING HOSPITAL CONDUCTING PATIENT CARE AND RESEARCH. THE INFIRMARY IS A TEACHING HOSPITAL OF HARVARD MEDICAL SCHOOL AND AN INTERNATIONAL CENTER FOR RESEARCH. IT HAS THE MOST COMPETITIVE PROGRAM IN THE COUNTRY FOR EYE, EAR, NOSE, AND THROAT RESIDENCY TRAINING AND THE WORLD'S LARGEST OPHTHALMIC FELLOWSHIP PROGRAM. IT IS PART OF A SYSTEM OF RELATED ENTITIES THAT PROVIDE SPECIALIZED MEDICAL CARE COLLECTIVELY KNOWN AS "MASSACHUSETTS EYE AND EAR INFIRMARY" ("MEEI"). |
| FORM 990, PART III, LINE 4A: | RESEARCH Ophthalmology: - ORMI Researchers First to Regrow Human Corneal Tissue Bruce Ksander, PhD and postdoctoral fellow Evi Kolovou, MD, as well as other ORMI members -James Zieske, PhD and Meredith Gregory-Ksander, PhD- have identified a way to enhance regrowth of human corneal tissue and restore vision, using a molecule known as ABCB5 that acts as a marker for rare limbal stem cells. Drs. Ksander and Kolovou were able to use antibodies detecting ABCB5 to zero in on the stem cells in tissue from deceased human donors, and use them to regrow anatomically correct, fully functional human corneas in mice. The ability to prospectively identify and isolate limbal stem cells will greatly enhance the success of corneal regeneration in patients with a limbal stem cell deficiency. -Researchers demonstrate drug-eluting lens can deliver sustained glaucoma medication for one month Joseph Ciolino (Cornea Center of Excellence) has worked closely with collaborators at Boston Children's Hospital and MIT to develop a drug-eluting contact lens that can deliver various pharmaceutical agents at a therapeutic rate every day for a full month. Recently, he and colleagues demonstrated for the first time the ability of the lens to deliver lantanopost, a common glaucoma medication. This is exciting news with potentially many therapeutic applications that could benefit a broad and diverse patient population. |
| Ocular Genomics Institute: | -The OGI Genomics Core provides state-of-the-art genomics services to members of the Department of Ophthalmology at Mass. Eye and Ear and Harvard Medical School. Services are also available to external academic investigators and commercial entities. In the past year, the Genomics core has performed genomic analyses of over 800 samples and sequencing of over 35,000 samples in support of research of many department members. The Genomics Core recently initiated whole genome sequencing using a non-amplified sample preparation method. Investigators who have utilized genomics core services are also working with the Mass. Eye and Ear Bioinformatics Center to analyze these data. -Genetic diagnostic testing: Through a CLIA-certified service, the OGI offers comprehensive genetic diagnostic testing for inherited eye diseases, including inherited retinal degenerations (IRDs), optic atrophy and glaucoma via the Genetic Eye Disease (GEDi) test. In the past year, over 250 samples submitted by investigators at MEEI and from outside institutions, have been analyzed using this test. A manuscript describing the performance of the GEDi test, which is highly accurate and reproducible, has been accepted for publication in the Nature journal Genetics in Medicine. -The Mass. Eye and Ear Bioinformatics Center, led by Dr. Xiaowu Gai, is supporting multiple investigators in the Department of Ophthalmology by providing broadly enabling bioinformatics expertise, infrastructure and shared resources. In addition, Dr. Gai co-leads an international consortium named Mitochondrial Disease Sequence Data Resource (MSeqDR) Consortium. This is a grass-root efforts involving over 100 international mitochondrial disease experts aiming to develop a centralized genomic resource for mitochondrial disease research, which has been designed, developed, and implemented by the MEEI Bioinformatics Center and is currently available online at https://mseqdr.org/. A review paper on MSeqDR was recently accepted by the journal Molecular Genetics and Metabolism. The United Mitochondrial Disease Foundation has also committed to continuous support for the project. -Gene Therapy Center, encompassing the research laboratory of Dr. Luk Vandenberghe and the Gene Transfer Vector Core, under the wider OGI umbrella. The Gene Transfer Vector Core (GTVC), which is directed by Drs. Vandenberghe and Ru Xiao is actively providing research-grade gene therapy vectors to Department and community investigators. Consultation regarding the design and execution phase of gene transfer experiments is also available. To date, the GTVC has generated over 400 adeno-associated virus preparations for about 24 research groups at MEEI, SERI, and outside research organizations. -Disease gene discovery: investigators in the OGI, led by Dr. Kinga Bujakowska in the Pierce lab, identified mutations in the IFT172 gene as a cause of inherited retinal degeneration. The studies reported in the journal Human Molecular Genetics showed that mutations in IFT172 can cause retinal degeneration alone, or in association with syndromic disease (published online August 2014). -Disease gene discovery: In a study published in JAMA Ophthalmology, the Engle Lab and members of OGI reported that mutations in the ryanodine receptor 1 (RYR1) cause of ophthalmoplegia, facial weakness, and malignant hyperthermia. This is important because total ophthalmoplegia can result from RYR1 mutations without overt skeletal myopathy. Patients carrying RYR1 mutations are at high risk of developing malignant hyperthermia. Ophthalmologists should be familiar with these important clinical associations. Date of publication: December 2013 (volume 131). -Phenotyping for future gene discovery: Moebius syndrome is a heterogeneous, rare congenital disorder defined by limited horizontal eye movement and facial weakness. To improve diagnostic assessment in Moebius syndrome, the Engle lab and members of the Department of Ophthalmology at CBH created more selective diagnostic subgroups and conducted genetic evaluation for three candidate genes in a cohort of 112 patients diagnosed with Moebius syndrome. They found that patients with exotropia, vertical gaze limitation, and ptosis did not have classic Moebius syndrome and most harbored TUBB3 mutations associated with CFEOM3. Thus, to optimize genetic analysis, they proposed adding "full vertical motility" to the minimum diagnostic criteria for Moebius syndrome. -Mechanism of disease: investigators in the OGI lead by Dr. Michael Farkas showed that mutations in genes that encode proteins called RNA splicing factors cause disease by disrupting the function of the retinal pigment epithelial cells of the retina. Mutations in RNA splicing factors are a common cause of inherited retinal degeneration. The findings, reported in the American Journal of Pathology in October 2014, provide important insight into way mutations in these genes cause vision loss, and make it possible to test treatments for these genetic forms of retinal degeneration. -Mechanism of disease: Members of the Engle lab previously reported that the ocular motility disorder ''Congenital fibrosis of the extraocular muscles type 1'' (CFEOM1) results from heterozygous mutations altering the motor and third coiled-coil stalk of the anterograde motor protein, KIF21A. In a study published this year in Neuron, they defined the oculomotor nerve developmental pathology of CFEOM1, established a gain-of-function mechanism for the disorder, and found that human motor or stalk mutations attenuate the autoinhibition of the Kif21a protein, providing in vivo evidence for mammalian kinesin autoregulation. Finally, they identified Map1b as a Kif21a-interacting protein and report that both CFEOM knock-in and Map1b knock-out mice also develop CFEOM. The interaction between Kif21a and Map1b highlights a selective vulnerability of the developing oculomotor nerve to perturbations of the axon cytoskeleton. Ocular Regenerative Medicine Institute: -Dean Eliott: Demonstrated survival of grafted embryonic stem cell derived RPE in AMD patients in a first-in-man trial. -Bruce Ksander, James Zieske: Identified limbal stem cells that repair and maintain the ocular surface. -Kip Connor, Neena Haider: Obtained funding from Brightfocus Foundation to pursue the development of a new genetic model for Choroidal Neovascular (wet) AMD. -Michael Young, Petr Baranov: Awarded the only vision related grant from the Bertarelli Program in Translational Neuroscience and Neuroengineering -James Zieske: Uncovered the function of thrombospondin-1 in repair of penetrating corneal wounds. -Darlene Dartt: Described the Role of PKC? activation in EGF-stimulated proliferation of rat and human conjunctival goblet cells. -Michael Young: Developed a novel stem cell therapy for retinitis pigmentosa using retinal progenitor cells, with a planned trial in 2015. -Demetrios Vavvas: Discovered that Mammalian STE20-like kinase 2, not kinase 1, mediates photoreceptor cell death during retinal detachment. -Petr Baranov and Michael Young: Described a novel substrate for the growth and maintenance of stem cells using polycaprolactone and RGB moieties. Infection Disease Institute: -The Gilmore Laboratory conducted the first genome analysis of Streptococcus pneumoniae from epidemic and non-epidemic conjunctivitis cases and identified a number of new virulence traits and vaccine candidates. -Michael Gilmore: Advised the President's Council of Advisors on Science and Technology about the problem of antibiotic resistance, which led to their "Report the President on Combating Antibiotic Resistance." http://www.whitehouse.gov/sites/default/files/microsites/ostp/PCAST/pcast_ carb_report_sept2014.pdf. -Michael S. Gilmore, James Chodosh, Marlene Durand, Wolfgang Haas: Launched the IDI January 1, 2014, and already have analyzed and archived over 1,000 bacterial specimens infections treated at Mass. Eye and Ear. -The Gilmore Laboratory conducted the first comprehensive genome-wide scans to identify traits of Staphylococcus aureus that are important in ocular as well as other infections. -The Gilmore Laboratory showed that antibiotic resistant strains of a leading cause of multidrug resistant hospital infection, Enteroccoccus faecium, derived from animal strains and not human commensal strains. Moreover, we showed that animal and human strains diverged about 3,000 years ago, as humanity began living in cities away from animals, and learned basic hygiene practices. -Michael S. Gilmore, James Chodosh, Marlene Durand, Lucia Sobrin, Wolfgang Haas: Began to develop and implement new diagnostic tests to detect difficult-to-diagnose infections of the eye. -Michael S. Gilmore, James Chodosh, Klaes Dohlman, Wolfgang Haas: Established new partnerships to improve the antimicrobial properties of ocular prosthetic devices. AMD Center of Excellence: -Kip Connor, Joan Miller, Demetrios Vavvas: Demonstrated that the receptor-interacting protein (RIP) ki |
| Glaucoma Center of Excellence: | -Working collaboratively with members of the Cornea Center of Excellence, members of the Glaucoma Center of Excellence described: -The functioning of a prosthesis embedded in an intraocular lens implant that wirelessly transmits information on the level of intraocular pressure. -The clinical course of keratoprosthesis glaucoma, recommending that glaucoma surgery be completed before, or combined with keratoprosthesis implantation. -Working with collaborators at the University of Illinois, Dr. Pasquale described a heighted risk of open angle glaucoma among women with early oophorectomy. -Working with collaborators from University of Michigan, Dr. Pasquale reported on an association between postmenopausal estrogen used and reduced risk of open-angle glaucoma using a healthcare relational database. -Dr. Janey Wiggs led an effort to describe the features of the LOXL1 knockout mouse, a murine model that shares some features with human exfoliation syndrome. This work was conducted in collaboration with members of the Retina Center of Excellence. -Drs. Pasquale and Wiggs working collaboratively with members of the Channing Division of Network Medicine at Brigham and Women's Hospital, described several modifiable risk factors for exfoliation glaucoma including time spent outdoors, lower dietary folate intake and high coffee consumption, using data from the Nurses Health Study and Health Professionals' Follow-up Study. With respect to time spent outdoors, Dr. Pasquale, along with several members of the Glaucoma Center of Excellence and faculty from the Comprehensive Eye Service, confirmed that time spent outdoors was associated with increased risk of exfoliation syndrome using a case control group from Mass Eye and Ear Infirmary combined with a case control group from Israel. -Dr. Pasquale, along with Dr. Robert Ritch, published the proceedings of The Glaucoma Foundation Think Tank 2013 Meeting on Exfoliation Syndrome, entitled "Exfoliation Syndrome: What we know and where we need to go". -On behalf of the GLAUGEN (Glaucoma Genes and Environment) study and the NEIGHBOR (National Eye Institute Glaucoma Human Genetics Collaboration) consortium, Glaucoma Center of Excellence investigators described several genetic loci for intraocular pressure. -Under the direction of Dr. Wiggs, the GLAUGEN (Glaucoma Genes and Environment) study and the NEIGHBOR (National Eye Institute Glaucoma Human Genetics Collaboration) consortium, was successfully converted to the NEIGHBORHOOD - NEIGHBOR Heritable Overall Operational Database, the largest case control dataset for primary open-angle glaucoma (POAG) with genotype calls for >5 million loci. This powerful dataset has been used to achieve several important milestones: -The NEIGHBORHOOD highlighted several genetic biomarkers in the vascular tone pathway associated with POAG. -The NEIGHBORHOOD database was used to describe several biochemical pathways that are operative in POAG including the GABA metabolism pathway. -In a series of 3 publications in Nature Genetics, the NEIGHBORHOOD dataset contributed data to an international effort that led to the discovery and validation for new genetic loci related to intraocular pressure, cup disc ratio and POAG. -The NEIGHBORHOOD dataset contributed to an understanding of the functional significance of the SIX1/SIX6 genomic region in relation to POAG. -The NEIGHBORHOOD dataset was used to demonstrate the CAV1/CAV2 genomic region is associated with paracentral visual loss in POAG. -Various member of the Glaucoma Center of Excellence along with members from the Comprehensive Eye Service, contributed to a survey of pre-operative blood tests in primary open-angle glaucoma (POAG) patients versus cataract surgery patients. The work suggests that POAG patients have higher IgG levels, pointing to a humoral immune deviation in POAG. -Dr. Teresa Chen published 2 papers regarding computer-based imaging of the nerve fiber layer in glaucoma patients. -Dr. Angela Turalba published work indicating that subtenons triamcinolone is not a viable option to enhance outcomes for glaucoma patients requiring glaucoma drainage implants. -Members of the Glaucoma Center of Excellence team described the effect of brominidine, an alpha 2 agonist that demonstrated a neuroprotective effect in the Low Pressure Glaucoma Treat Study, on retinal vascular autoregulation in normal tension glaucoma patients. Diabetic Eye Disease Center of Excellence: -Mara Lorenzi: -In a preclinical study using the rat model of diabetic retinopathy, it was found that retinal vessels become dependent upon a small increase in TGF-beta signaling. Thus, regulation of the TGF-beta system may modulate the severity and progression of retinopathy. -A clinical study in type I diabetic patients is identifying a defective myogenic response to pressure of retinal arteries as both a marker of diabetic retinopathy risk and an accelerator of retinopathy (collaboration with Sobrin, Feke, and Pasquale). -Pat D'Amore, Joe Arboleda: Developed a new mouse model of mural cell deletion that replicates the early stages of diabetic microangiopathy in the adult retina. This new mouse model can be used to study acute changes related to loss of mural cells in the retinal microvasculature. -Andrius Kazlauskas: Vitreous is capable of inducing regression of neovessels, and this activity wanes as patients develop proliferative diabetic retinopathy (PDR). This suggests that PDR arises not only because of an accumulation of pro-angiogenic factors (such as VEGF) in vitreous. A decline in the vitreous's intrinsic ability to promote regression of neovessels may be an additional contributor. Such discoveries set the stage for subsequent studies to develop adjuvant therapies for patients with PDR. -Lucia Sobrin: In study of Korean patients with diabetes, it was determined that extensive capillary nonperfusion in the retina on fluorescein angiography greatly increased the risk of progression of chronic kidney disease. -Magali Saint-Geniez: Demonstrated that a deficiency in fatty acid binding protein 4 (FABP4) is protective against oxygen-induced retinopathy in mice, identifying FABP4 as a potential target of pathologic retinal angiogenesis in proliferative retinopathies. -Dean Eliott: Participated in the iDEAL Study, a phase 2 clinical trial investigating whether the drug iCo-007, an antisense inhibitor targeting the C-raf kinase messenger RNA, could help treat patients with type 1 or type 2 diabetes and diabetic macular edema. Ocular Oncology Center of Excellence: -Shizuo Mukai: -Developed an iPhone app for detection of leukocoria -Analysis of 25 year experience with proton bean therapy for retinoblastoma. -Demetrios Vavvas, Evangelos Gragoudas: Demonstrated the efficacy of Visudyne in retinoblastoma cell lines without need for photoactivation -Kathryn Colby, Fred Jakobiec: Characterized distinguishing clinical and immunochemical features of neoplastic epithelial lesions of the conjunctiva. -Shizuo Mukai, Fred Jakobiec: Developed a model for pathogenesis of infantile medulloepithelioma. -Suzanne Freitag (in progress): Retrospectively analyzed causes for and outcomes of orbital exenterations over the last 10 years -Kathryn Colby, Rebecca Stacy: Developed a collaboration with MGH Melanoma Center to evaluate the role of genetic mutations in prognosis of conjunctival melanoma. -Eleftherios Paschalis, Mien Hoang, Joan Miller, Evangelos Gragoudas, Demetrios Vavvas: Demonstrated that metformin, an anti-diabetic drug, inhibited the in vitro proliferation of retinoblastoma cells at levels well above those tolerated in vivo. This suggests that metformin's potential anticancer effects, observed in epidemiological studies, may be limited to specific tumor types and/or related to indirect mechanisms not observed under laboratory conditions. -Bruce Ksander, Joan Miller, Evangelos Gragoudas, Demetrios Vavvas: Demonstrated that aminoimidazole carboxamide ribonucleotide (AICAR), an AMP-dependent kinase (AMPK) activator, inhibits uveal melanoma cell proliferation partially though activating the AMPK pathway and downregulating cyclins A1 and D1. -Joan Miller, Evangelos Gragoudas, Demetrios Vavvas: Demonstrated a novel role of the YAP-TEAD pathway in retinoblastoma, and demonstrated the therapeutic potential of verteporfin as an adjuvant therapeutic tool in treating retinoblastoma patients. The clinically used photosensitizer verteporfin was found to be a potent inhibitor of retinoblastoma cell growth, disrupting proto-oncogenes downstream of the YAP-TEAD signaling pathway, and downregulating the pluripotential marker OCT4. -Yoshihiro Yonekawa, Ivana Kim, Evangelos Gragoudas, Frederick Jakobiec, Rebecca Stacy: Presented the first reported case of choroidal melanoma that developed a late recurrence and aggressive metastasis to the skull base without evidence of hepatic involvement, and described its clinical, pathologic, and genetic findings. The case was characterized by delayed on |
| OTOLARYNGOLOGY: | -Scientists Restore Hearing in Noise-Deafened Mice A team including M. Charles Liberman, Ph.D., have restored the hearing of mice partly deafened by noise, using advanced tools to boost the production of a key protein in their ears. By demonstrating the importance of the protein, called NT3, in maintaining communication between the ears and brain, these new findings pave the way for research in humans that could improve treatment of hearing loss caused by noise exposure and normal aging. Wan G, Gmez-Casati ME, Gigliello AR, Liberman C, Corfas G. Neurotrophin-3 regulates ribbon synapse density in the cochlea and induces synapse regeneration after acoustic trauma. Elife. 2014 Oct 20;3. -Audio games may improve hearing in noisy environments Daniel B. Polley, Ph.D., and colleagues have programmed a new type of game that has trained both mice and humans to enhance their ability to discriminate soft sounds in noisy backgrounds. Their findings were published in PNAS Online Early Edition the week of June 9-13, 2014. In the experiment, adult humans and mice with normal hearing were trained on a rudimentary 'audiogame' inspired by sensory foraging behavior that required them to discriminate changes in the loudness of a tone presented in a moderate level of background noise. Their findings suggest new therapeutic options for clinical populations that receive little benefit from conventional sensory rehabilitation strategies. Whitton JP, Hancock KE, Polley DB. Immersive audiomotor game play enhances neural and perceptual salience of weak signals in noise. Proc Natl Acad Sci USA. 2014 Jun 24;111(25):E2606-15. -FGF23 hormone deficiency may lead to hearing loss and malformation Fibroblast growth factor 23 (FGF23) is a circulating hormone important in mineral homeostasis. Abnormal serum levels of FGF23 result in systemic pathologies in humans and mice, including rickets and calcinosis. Konstantina Stankovic, M.D., Ph.D., and colleagues sought to uncover the role FGF23 plays in the auditory system due to similarities between ear and kidney development. They found that FGF23 is expressed throughout the cochlea in mice and demonstrated that complete loss of FGF23 causes profound deafness, while partial loss results in moderate hearing loss at high frequencies. These observations are consistent with mixed conductive and sensorineural pathology of both middle and inner ear origin. Loss of the hormone causes dramatic bone abnormalities. Given the extensive middle ear malformations and the overlap of FGF23 activity and Eustachian tube development, this work suggests a possible role for FGF23 in otitis media. Lysaght A, Yuan Q, Fan Y, Kalwani N, Caruso P, Cunnane M, Lanske B, Stankovic KM. FGF23 deficiency leads to mixed hearing loss and middle ear malformation in mice. Plos One 2014; 2014 Sep 22;9(9):e107681. -Decoding Sounds' Source Mitchell Day, Ph.D., and Bertrand Delgutte, Ph.D., gained new insight into how localized hearing works in the brain. In the experiment, they recorded the electrical activity of individual neurons in an essential lower-level auditory brain area called the inferior colliculus (IC), while an animal listened to sounds coming from different directions. They found that the location of a sound source could be accurately predicted from the pattern of activation across a population of less than 100 IC neurons - i.e., a particular pattern of IC activation indicated a particular location in space. Researchers further found that the pattern of IC activation could correctly distinguish whether there was a single sound source present or two sources coming from different directions. Day ML, Delgutte B. Decoding sound source location and separation using neural population activity patterns. J Neurosci. 2013 Oct 2;33(40):15837-47. -Researchers Show that Efferent Feedback Slows Cochlear Aging Stphane Maison, Ph.D., M. Charles Liberman, Ph.D., and colleagues have shown that the Olivocochlear (OC) efferent reflex dramatically slows age-related hearing loss. The team surgically lesioned the OC efferent reflex and tracked hearing changes in mice exposed only to quiet ambient noise. After a year, mice with normal OC systems did not show significant hearing loss, while those with a lesioned efferent reflex presented damages to hair cells and auditory-nerve synapses. The lack of OC efferent reflex had turned middle-age ears into senescent ears. Liberman MC, Liberman LD, Maison SF. Efferent feedback slows cochlear aging. J Neurosci. 2014 Mar 26;34(13):4599-607. -New Findings in Protective Mechanisms for Hearing Loss Mingqian Huang, Ph.D., Albena Kantardzhieva, Ph.D., M. Charles Liberman, Ph.D., Zheng-Yi Chen, Ph.D., and colleagues in the Eaton-Peabody Laboratories, have created a new mouse model in which, by expressing a gene in the inner ear hair cells, protects the mice from age-related hearing loss (ARHL) and noise-induced hearing loss (NIHL). Their research, described in the Sept. 18, 2013 issue of the Journal of Neuroscience, provides new insight into protec-tive mechanisms for hearing loss and suggests the potential for future molecular approaches, which may include gene therapy or medicine, to treat ARHL and NIHL. Huang M, Kantardzhieva A, Scheffer D, Liberman MC, Chen ZY. Hair cell overexpression of Islet1 reduces age-related and noise-induced hearing loss. J Neurosci. 2013 Sep 18;33(38):15086-94 Bioengineering: -Prototype Chip Makes Possible Fully Implantable Cochlear Implant Konstantina Stankovic, M.D., Ph.D. and colleagues have designed a protype system-on-chip (SoC) that could make possible a fully implanted cochlear implant. Presented on Feb. 11, 2014 at the IEEE International Solid State Circuits Conference in San Francisco. -Scientists Create New System that could be used to Treat Deafness, Other Genetic Conditions A team of Harvard and Massachusetts Eye and Ear researchers, including Zheng-Yi Chen, Ph.D., have developed a system that uses commercially available molecules called cationic lipids - long, greasy molecules that carry a positive charge - to efficiently deliver genome-editing proteins into cells, and have even demonstrated that the technology can be used to perform genome editing in living animals. Zuris JA, Thompson DB, Shu Y, Guilinger JP, Bessen JL, Hu JH, Maeder ML, Joung JK, Chen ZY, Liu DR. Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo. Nat Biotechnol. 2014 Oct 30 Clinical Practice: -Researchers present new findings concerning the inner ear's response to cochlear implant electrodes. The surgical placement of a cochlear implant is considered to be the state-of-the-art treatment for bilateral profound sensorineural hearing loss in cases where a conventional hearing aid is no longer useful. In a recent paper published in the October 2014 issue of Otology and Neurotology, Mohammad Seyyedi, M.D., a research fellow, and Joseph B. Nadol, Jr., M.D., of the Otopathology Research Laboratory at Mass. Eye and Ear, published their findings concerning the pattern and degree of tissue response adjacent to a cochlear implant electrode in humans. The paper demonstrates that occasionally a severe inflammatory response may result from cochlear implantation, in turn resulting in failure of the implant. It is hoped that this study will focus attention on the need to identify materials and techniques that limit the inflammatory response of the inner ear to the presence of a cochlear implant. Seyyedi M, Nadol JB Jr. Intracochlear inflammatory response to cochlear implant electrodes in humans. Otol Neurotol. 2014 Oct;35(9):1545-51. -Aspirin Intake May Halt Growth of Vestibular Schwannomas Konstantina Stankovic, M.D., Ph.D., led a study that demonstrated, for the first time, that aspirin intake correlates with halted growth of vestibular schwannomas, a sometimes lethal intracranial tumor that typically causes hearing loss and tinnitus. Kandathil CK, Dilwali S, Wu CC, Ibrahimov M, McKenna MJ, Lee H, Stankovic KM. Aspirin intake correlates with halted growth of sporadic vestibular schwannoma in vivo. Otol Neurotol. 2014 Feb;35(2):353-7. -The Supraclavicular Artery Flap for Head and Neck Daniel G. Deschler, M.D., FACS was lead author on a study conducted on 45 patients with defects related to malignant and nonmalignant disease undergoing reconstructive surgery. The team demonstrated the versatility of the supraclavicular artery (SCA) flap in head and neck reconstruction and offered technical highlights to improve the efficiency of flap harvest. The SCA flap is said to be a versatile and reliable reconstructive option for head and neck defects. Emerick KS, Herr MW, Lin DT, Santos F, Deschler DG. Supraclavicular artery island flap for reconstruction of complex parotidectomy, lateral skull base, and total auriculectomy defects. JAMA Otolaryngol Head Neck Surg. 2014 Sep;140(9):861-6. doi: 10.1001/jamaoto.2014.1394. Radiology: -The radiologists wrote or participated in 35 papers inc |
| FORM 990, PART III, LINE 4B: | EDUCATION ACADEMIC PROGRAMS: OTOLARYNGOLOGY: - 18 RESIDENTS - 11 CLINICAL FELLOWS - 55 RESEARCH FELLOWS - 2 RESEARCH RESIDENTS OPHTHALMOLOGY: - 24 RESIDENTS - 24 CLINICAL FELLOWS - 117 RESEARCH FELLOWS Ophthalmology: Educational Highlights: - The ACGME conducted a site visit of the Ophthalmology Residency Training Program in October 2013, and in May 2014 the Residency Review Committee reviewed the findings and awarded the program an excellent four-year re-accreditation with a self-study scheduled for July 2018. - Several new clinical fellowships have been initiated: Medical Retina (Director: Deeba Husain), Inherited Retinal Degenerations (Director: Eric Pierce), Inherited Retinal Degenerations and Pediatric Medical Retina (Co-directors: Eric Pierce and Anne Fulton, Children's Hospital), and Vision Rehabilitation (Director: Mary Lou Jackson) |
| Symposia and Conferences: | -Inaugural ORMI symposium: Ophthalmology represents a valuable arena for advancing regenerative medicine due the anatomical isolation, physical accessibility and immune privilege of the eye. To synthesize the latest developments in this field, the HMS Department of Ophthalmology presented the first Symposium on Ocular Regeneration: Cell Therapy and Regeneration in the Retina. The symposium was held on October 23, 2014 and co-chaired by Michael Young, PhD and Demetrios Vavvas, MD, PhD who also co-direct the Ocular Regenerative Medicine Institute. Experts from around the world delivered thought-provoking presentations and engaged participants in insightful, open-ended panel discussions at the end of each moderated session. The wide array of topics ranged from refining surgical techniques in preclinical models to optimizing strategies for isolating, culturing, and preserving stem cells for cellular therapies. Speakers explored the fundamental mechanisms of neuronal death in a variety of eye diseases, including age-related macular generation (AMD), glaucoma, and retinitis pigmentosa. Although the meeting focused primarily on regeneration of the retina, investigations from other parts of the eye (including the cornea) yielded insight into regenerative and cell-based therapeutic strategies overall. Basic stem cell biology was also discussed, down to the genetics and epigenetic mechanisms of cellular reprogramming and homeostasis. Attendees described the symposium as "great" and "excellent" overall and "...a great opportunity to communicate with other scientist on a high level and to learn from them." -3rd International Biennial Symposium on AMD: On October 24-25, 2014, the HMS Department of Ophthalmology hosted the 3rd International Biennial Symposium on AMD, co-chaired by Joan Miller, MD, FARVO and AMD Center of Excellence co-directors Patricia D'Amore, PhD, MBA, FARVO and Ivana Kim, MD. Presentations focused on the pathogenesis of early AMD. The complement system, a component of innate immunity, featured prominently throughout the symposium. Additional immune-related topics discussed during the event included inflammasome activation and cellular immune modulators such as macrophages, microglial cells and mast cells. Other emerging topics that were covered included oxidative stress and micro RNAs as biomarkers and therapeutic targets in AMD. Researchers are also aggressively pursuing potential therapies for the atrophic or "dry" form of AMD. Areas of interest highlighted at the meeting included mechanisms of photoreceptor death and early-phase clinical investigation of stem cell therapy. The symposium drew nearly 250 participants. -Neuro-ophthalmology Fall Festival: This unique workshop provided a comprehensive overview on the diagnosis and management of common or important neuro-ophthalmic disorders, including optic neuritis, ischemic optic neuropathy, vertical diplopia, giant cell arteritis, idiopathic intracranial hypertension, neuro-ophthalmology of multiple sclerosis, and a variety of eye movement disorders. The course included case presentations and lectures by the faculty. -Annual Meeting and Alumni Reunion: More than 300 HMS Department of Ophthalmology faculty, alumni, and trainees gathered for a three-day festival of events that included the Annual Meeting and Alumni Reunion, tours of Mass. Eye and Ear and Schepens, a celebratory dinner, and visits to Fenway Park and the Museum of Fine Arts from June 20 to 22, 2014. On Friday, scientific lectures were given by 12 HMS faculty showcasing their current investigations in eye research. Topics spanned telemedicine for diabetic retinopathy, genetics of retinitis pigmentosa, advances in retinal imaging, resident education, and management of acute Steven's Johnson Syndrome in children. On Saturday, the Alumni Reunion included Dr. Joan Miller's update on the state of the department, alumni presentations, and the Distinguished Research and Clinical Achievement Award presentations. New Courses: -Uveitis Instruction Course: This day-long course reviews the diagnosis and treatment of common uveitis conditions and covers diagnostic testing, imaging and treatment approaches to ocular inflammatory disease. Invited faculty speakers will include uveitis specialists from Bascom Palmer, Cleveland Clinic, Emory and Weill Cornell in addition to uveitis faculty from Harvard Medical School. -Soft Tissue Suture Course: Junior residents from Harvard Medical School/Mass. Eye and Ear, Tufts University, Boston University, Brown University, and Yale University are invited to attend this course on the principles of soft tissue suturing and suture materials. Participants also attend a wet lab session with video and live instruction using pig feet and ears. OTOLARYNGOLOGY: -This year we celebrated the graduation of the class of 2014 at a June 27th ceremony held in the Meltzer auditorium. Our outstanding graduates included residents Megan M. Abbott, M.D., M.P.H., Gillian Diercks, M.D., Aaron K. Remenschneider, M.D., M.P.H., and Ahmad R. Sedaghat, M.D., Ph.D. -We also celebrated the graduation of eight clinical fellows: -Prabhat K. Bhama, M.D., M.P.H., Facial Plastic and Reconstructive Surgery -David H. Jung, M.D., Ph.D., Neurotology -Giant C. Lin, M.D., Rhinology -Joshua C. Meier, M.D., Rhinology -Paul M. Paddle, M.D., Laryngology -Derek J. Rogers, M.D., Pediatric Otolaryngology -Aaron D. Tward, M.D., Ph.D., Neurotology -Bharat B. Yarlagadda, M.D., Head and Neck/Microvascular -Following graduation, we welcomed several new trainees in otolaryngology at Mass. Eye and Ear. Four new residents joined the program, including Jennifer Fuller, M.D., Deepa Galaiya, M.D., Anuraag Parikh, M.D., and Sid Puram, M.D., Ph.D. -We also welcomed eight new clinical fellows: -Gillian Diercks, M.D., Pediatric Otolaryngology -Neerav Goyal, M.D., Head and Neck/Microvascular -Inna Hussain, M.D., Laryngology -Nathan Jowett, M.D., Facial Plastic and Reconstructive Surgery -Rahul Modi, M.D., Thyroid and Parathyroid Surgery -Aaron Remenschneider, M.D., M.P.H., Neurotology -Ahmad Sedaghat, M.D., Ph.D., Rhinology -William Yao, M.D., Rhinology -In other education news, we are enjoying our new state-of-the-art Otolaryngology Surgical Training Laboratory immensely and have held several major courses there over the past year, from resident dissection courses to CME courses with international attendees. -We're also extremely excited about the creation of a Fellowship for Balance and Vestibular Disorders, a one-year post-residency fellowship program based at Mass. Eye and Ear, to train qualified physicians in the diagnosis and management of patients with balance and vestibular disorders. The first fellow will be selected to start in July 2015. -New Textbook: Tessa Hadlock, M.D., and Mack Cheney, M.D., recently celebrated the release of Facial Surgery: Plastic and Reconstructive, published by CRC Press. The book provides basic knowledge in facial plastic surgery for residents as well as experienced practitioners. With detailed descriptions of the latest surgical techniques, it captures and highlights meaningful new surgical methods with a deliberate emphasis on evidence-based medicine. evidence-based medicine. |
| FORM 990, PART III, LINE 4C: | CLINICAL CARE Ophthalmology: -Mass. Eye and Ear acquired two private ophthalmology practices. To the west, the cornea and refractive surgery practice of Jonathan Talamo, MD, Kathryn Masselam Hatch, MD and Karen Zar, OD (now Mass. Eye and Ear, Waltham) offers a full range of specialty eye care, including cataract surgery, on-site laser vision correction, corneal crosslinking and optometric services. Extending to the south, Mass. Eye and Ear purchased Southern New England Retina Associates located in Providence, Rhode Island (now Mass. Eye and Ear, Providence) and Plainville, Mass. (now Mass. Eye and Ear, Plainville). Magdalena Krzystolik and Paul Greenberg specialize in the treatment of retinal diseases, including AMD, diabetic retinopathy and retinal detachment. -Mass. Eye and Ear faculty Roberto Pineda II, Ula Jurkunas, Kathryn Hatch and Peter Veldman, are among a handful of corneal surgeons on the East Coast with advanced training in Descemets Membrane Endothelial Keratoplasty (DMEK). Developed in the Netherlands six years ago, DMEK is the thinnest and most advanced form of corneal transplantation to date. In contrast to other partial thickness corneal transplant procedures, DMEK replaces only the diseased tissue without need for additional or redundant tissue, which allows for a more precise and anatomically correct approach. As a result, DMEK has demonstrated lower risk of rejection, faster recovery, and better vision (a higher percentage of patients achieve 20/20 vision) than prior forms of corneal transplant. Dr. Veldman, a cornea and refractive surgeon, recently returned from a year-long fellowship at a high volume DMEK center in Portland, Oregon. He plans to host visiting surgeons for observation of live DMEK surgery at Longwood, as well as simulated surgeries with whole eyes and transplant tissue in a lab setting. NEW EQUIPMENT & TECHNOLOGY: -Aura Laser - Morse Laser Center -Hopkins Telescope - Longwood -Fundus Lens - Retina Consultants -Microscope - Eye Plastics, Eye Pathology -Keeler Laser Indirect Ophthalmoscope- Morse Laser Center -Spectralis Optical Coherence Tomography - DeGunzberg Imaging Center -Fundus camera, triple port adapter, Sonomed Escalon - Retina Consultants -Computer Upgrades (#82) - Ophthalmology clinical support and administrative personnel -Camera - Resident use in Emergency Department -OPD Scan III & Software - Cornea Service -Visante Optical Coherence Tomography and Corneal Topography Sys - Longwood -Equipment Upgrades - new Waltham, Providence, Plainville offices -Beamsplitter/video system/monitor -Longwood |
| COMMUNITY SERVICE ACTIVITIES: | LOCAL/REGIONAL -Louis Pasquale served as the Massachusetts spokesperson for World Glaucoma Awareness Week. Support Groups: -Mass. Eye and Ear Eye Plastics hosted a quarterly Thyroid Eye Disease support group, which is led by Suzanne Freitag, MD. This support group is run in collaboration with the Graves Disease and Thyroid Foundation along with MGH endocrinology and Dr. Greg Randolph of Mass. Eye and Ear ENT. -Mass. Eye and Ear Vision Rehabilitation Support Group runs weekly for 8 weeks in the Vision Rehabilitation Clinic, and is led by a Mass. Eye and Ear social worker and a social worker who has low vision. -Vision and Hearing Screenings for Children and Young Adults,Neighborhood House Charter School (Dorchester) Community Forums, Lectures and Special Events: -Members of the Department participated for the second year at Stoneham Town Day on September 13, 2014 on the Stoneham Town Common. Thousands in the Stoneham and surrounding communities came out to join in the festivities which included over 100 exhibitors with lots of food and games for children and information for adults. The volunteers spread the word about our full-service facility on Montvale Avenue and our Retina Consultants on Woodland Road. Screenings: -Members of the department provided comprehensive eye exams to children and leaders-in-training at Camp Harbor View. Of the 113 screened, 20 were advised to see their own providers to address refractive errors and 17 were advised to seek follow-up by a pediatric ophthalmologist-two of whom needed urgent follow up. Camp Harbor View is an initiative of the not-for-profit Camp Harbor View Foundation, Inc. in partnership with the City of Boston and the Boys & Girls Clubs of Boston. The camp offers close to 800 children-ages 11 to 14 and living in Boston's at-risk neighborhoods-the opportunity to participate in a four-week program offering traditional "summer camp" activities. -Year-Up Vision Clinic - Caregivers at Mass. Eye and Ear, Longwood, teamed up with the Vision Coalition, a local nonprofit that performs vision screenings, to provide complete eye exams and eyeglasses for two groups of students from Year-Up Boston, an organization that empowers low-income young adults to leap from poverty to professional careers in one year. Twenty-three patients were examined and all left with the knowledge that they would soon receive the eyeglasses they need to see clearly and to succeed in school and in internships. |
| OTOLARYNGOLOGY: | -Mass. Eye and Ear recently opened a satellite office in Medford, Mass., with Mass. Eye and Ear general otolaryngologist H. Gregory Ota, M.D., serving as Medical Director of the practice. Dr. Ota has been on staff at Mass. Eye and Ear since 1986 and has served as Director of the Emergency Department's Otolaryngology Service since 2011. -We are also in the process of building an otolaryngology presence at Mass. Eye and Ear's Longwood office, with both ambulatory and operating room volume. Community Service Activities: -Faculty and staff in the Otolaryngology Department engage in a variety of community service activities throughout the year. From free, public cancer screenings for skin cancer and head and neck cancer to public seminars on hearing loss, sinus disease and thyroid cancer, our team is dedicated to promoting public health through prevention and raising awareness in the community. -Onsite Head and Neck Cancer Screening at main campus -Expanded Public Forums, including "Have You Heard" the "Sinusitis Seminar" and "Thyroid Conference" Anesthesiology: -Successful implementation of the Inpatient Hospitalist Service, a division of the Department of Anesthesia. Radiology: -New Equipment and Technology: -A trial of a 3D Accuitomo CT system was continued through FY14 and will continue for 1st quarter of FY15. The system will then be leased for next 3-years or until new technology on the cone beam becomes available. -Mass. Eye and Ear purchased and installed a brand-new CT-scan system - the GE Discovery CT 750 HD - in just one week. The new system offers fast, high resolution imaging and state-of-the-art dual energy allowing for improved quality and diagnostic capability. The new system also has allowed us to reduce the radiation dose on multiple exams, especially related to pediatrics. The new system went live on August 12th. -A new Philips EPIQ 5G Ultrasound System was also purchased and implemented. This system allows for unprecedented advances in premium ultrasound performance, exceptional image quality and intelligence that provides automated views and quantification. -The siting and evaluation process for a 2nd MRI system began in FY14 and further planning will continue in FY15. |
| FORM 990, PART VI, LINE 1A: | THE INFIRMARY'S BYLAWS STATE THE FOLLOWING: THERE SHALL BE AN EXECUTIVE COMMITTEE CONSISTING OF THOSE INDIVIDUALS WHO ARE SERVING AS MEMBERS OF THE EXECUTIVE COMMITTEE OF THE MEMBER. THE EXECUTIVE COMMITTEE SHALL HAVE THE POWER TO TRANSACT ALL EMERGENCY BUSINESS OF THE CORPORATION DURING THE PERIOD BETWEEN THE MEETINGS OF THE BOARD OF DIRECTORS. THE EXECUTIVE COMMITTEE SHALL ALSO TRANSACT SUCH BUSINESS, PERFORM SUCH DUTIES, AND EXERCISE SUCH POWERS AS MAY BE DIRECTED OR DELEGATED BY THE BOARD OF DIRECTORS FROM TIME TO TIME. THE EXECUTIVE COMMITTEE SHALL KEEP A RECORD OF ITS PROCEEDINGS. ALL ACTIONS OF THE EXECUTIVE COMMITTEE SHALL BE REPORTED TO THE BOARD OF DIRECTORS AT ITS NEXT REGULAR MEETING. FORM 990, PART VI, LINE 7A: THE GOVERNOR OF THE COMMONWEALTH HAS THE AUTHORITY TO APPOINT TWO DIRECTORS. THE BYLAWS OF THE INFIRMARY STATE THAT THE REMAINING DIRECTORS ARE THOSE INDIVIDUALS SERVING AS DIRECTORS OF ITS SOLE MEMBER, THE FOUNDATION OF THE MASSACHUSETTS EYE AND EAR INFIRMARY, INC. ("THE FOUNDATION"). |
| FORM 990, PART VI, LINE 7B: | THE FOUNDATION IS THE SOLE MEMBER OF THE INFIRMARY AND RETAINS THE AUTHORITY TO MAKE DECISIONS REGARDING THE INFIRMARY. |
| FORM 990, PART VI, LINE 11B: | THE INFIRMARY'S FORM 990 IS PREPARED BY PRICEWATERHOUSECOOPERS, LLP USING INFORMATION PREPARED BY MANAGEMENT. AFTER THE FORM 990 IS COMPLETED, IT IS REVIEWED BY THE DIRECTOR OF FINANCE OPERATIONS. THE FORM 990 IS THEN PRESENTED TO THE FINANCE COMMITTEE FOR REVIEW AND APPROVAL AS AUTHORIZED BY THE BOARD OF DIRECTORS. THE BOARD OF DIRECTORS ARE ALSO GIVEN THE FORM 990 FOR REVIEW WITH TIME TO SUBMIT COMMENTS AND QUESTIONS BEFORE FINAL FILING. |
| FORM 990, PART VI, LINE 12C: | MEMBERS OF THE STAFF ARE REQUIRED TO DISCLOSE CONFLICTS OF INTEREST TO THEIR CHIEF OF SERVICE OR DEPARTMENT AND DIRECTOR OF LABORATORY/UNIT. MEMBERS OF THE BOARD OF DIRECTORS ARE REQUIRED TO DISCLOSE ANNUALLLY, IN WRITING, ANY INTERESTS THAT COULD GIVE RISE TO CONFLICTS. THE OFFICE OF THE INTERNAL LEGAL COUNSEL OBTAINS AND REVIEWS THE ANNUAL CONFLICTS OF INTEREST STATEMENTS SUBMITTED BY MEMBERS OF THE BOARD OF DIRECTORS, AND REPORTS ON THE SAME TO THE AUDIT AND COMPLIANCE COMMITTEE OF THE BOARD. WITH RESPECT TO INTERESTS DISCLOSED BY BOARD MEMBERS THAT COULD GIVE RISE TO CONFLICTS OF INTEREST, THE INTERNAL LEGAL COUNSEL REVIEWS ALL TRANSACTIONS BETWEEN SUCH INTERESTS AND AFFILIATES OF THE INFIRMARY, TO DETERMINE WHETHER THESE TRANSACTIONS WERE CONDUCTED AT ARM'S LENGTH. |
| FORM 990, PART VI, LINE 15: | THE CHAIRMAN OF THE COMPENSATION COMMITTEE OF THE BOARD OF THE INFIRMARY PRESENTS A RECOMMENDATION TO THE COMPENSATION COMMITTEE WHO HAVE FINAL APPROVAL OF THE CEO'S BASE SALARY AND BONUS AMOUNT. THE CEO RECOMMENDS EXECUTIVE SALARIES TO THE COMPENSATION COMMITTEE OF THE BOARD WHO HAS FINAL AUTHORIZATION TO APPROVE IT. TOTAL COMPENSATION FOR THE CEO, CHIEFS AND VICE PRESIDENTS, INCLUDING BONUS PAYMENTS, INCLUDING COMPARABILITY DATA, IS ANALYZED BY INDEPENDENT COMPENSATION CONSULTANTS AND IS DETERMINED TO BE REASONABLE. |
| FORM 990, PART VI, LINE 19: | SUMMARIZED FINANCIAL STATEMENTS ARE AVAILABLE ON THE INFIRMARY'S WEBSITE: WWW.MASSEYEANDEAR.ORG. AUDITED FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. THE INFIRMARY'S GOVERNING DOCUMENTS AND FORM 990 ARE AVAILABLE UPON REQUEST. THE CONFLICT OF INTEREST POLICY IS ALSO AVAILABLE UPON REQUEST. FORM 990, PART XI, LINE 9: PERIODIC PENSION PLAN COST $(7,956,773) |
Schedule R IRS990ScheduleR
Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (6 entries)
| Address Line1USAddress/AddressLine1 | CityUSAddress/City | StateUSAddress/State | ZIP CodeUSAddress/ZIPCode | EINEIN | Primary ActivitiesPrimaryActivitiesTxt | Legal Domicile StateLegalDomicileStateCd | Exempt Code SectionExemptCodeSectionTxt | Public Charity StatusPublicCharityStatusTxt | Business Name Line1DirectControllingEntityName/BusinessNameLine1 | Controlled OrganizationControlledOrganizationInd |
|---|---|---|---|---|---|---|---|---|---|---|
| FDN OF THE MASS EYE & EAR INFIRMARYINC | ||||||||||
| 243 CHARLES STREET | BOSTON | MA | 02114 | 042785453 | PARENT | MA | 501(C)(3) | 9 | NA | false |
| MASSACHUSETTS EYE & EAR ASSOCIATES INC | ||||||||||
| 243 CHARLES STREET | BOSTON | MA | 02114 | 222658209 | PATIENT CARE | MA | 501(C)(3) | 9 | FOUNDATION | Yes (true) |
| CIRCLE COMPANY INC | ||||||||||
| 243 CHARLES STREET | BOSTON | MA | 02114 | 042801791 | TITLE HOLDING | MA | 501(C)(25) | N/A | FOUNDATION | Yes (true) |
| EMBANKMENT SERVICES INC | ||||||||||
| 14 DAVID G MUGAR WAY | BOSTON | MA | 02114 | 043272865 | SUPPORTNG ORG | MA | 501(C)(3) | 11 - TYPE 1 | FOUNDATION | Yes (true) |
| MASS EYE & EAR INFIRMARY PENSION PLAN | ||||||||||
| 243 CHARLES STREET | BOSTON | MA | 02114 | 046067238 | PENSION PLAN | MA | 401(A) | N/A | NA | false |
| SCHEPENS EYE RESEARCH INSTITUTE INC | ||||||||||
| 20 STANIFORD STREET | BOSTON | MA | 02114 | 042129889 | RESEARCH | MA | 501(C)(3) | 7 | FOUNDATION | Yes (true) |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Annts Rnts Rylts | false | ReceiptOfIntAnntsRntsRyltsInd |
| Gift Grnt Or Cap Contri To Oth Org | Yes (true) | GiftGrntOrCapContriToOthOrgInd |
| Gift Grnt Cap Contri From Oth Org | Yes (true) | GiftGrntCapContriFromOthOrgInd |
| Loans Or Guarantees To Other Org | Yes (true) | LoansOrGuaranteesToOtherOrgInd |
| Loans Or Guarantees From Oth Org | false | LoansOrGuaranteesFromOthOrgInd |
| Div Related Organization | false | DivRelatedOrganizationInd |
| Asset Sale To Other Org | false | AssetSaleToOtherOrgInd |
| Asset Purchase From Other Org | false | AssetPurchaseFromOtherOrgInd |
| Asset Exchange | false | AssetExchangeInd |
| Rental Of Facilities To Oth Org | false | RentalOfFacilitiesToOthOrgInd |
| Rental Of Fclts From Oth Org | Yes (true) | RentalOfFcltsFromOthOrgInd |
| Perform Of Services For Oth Org | false | PerformOfServicesForOthOrgInd |
| Perform Of Services By Other Org | Yes (true) | PerformOfServicesByOtherOrgInd |
| Sharing Of Facilities | false | SharingOfFacilitiesInd |
| Paid Employees Sharing | Yes (true) | PaidEmployeesSharingInd |
| Reimbursement Paid To Other Org | Yes (true) | ReimbursementPaidToOtherOrgInd |
| Reimbursement Paid By Other Org | Yes (true) | ReimbursementPaidByOtherOrgInd |
| Transfer To Other Org | Yes (true) | TransferToOtherOrgInd |
| Transfer From Other Org | false | TransferFromOtherOrgInd |
Transactions Related Org TransactionsRelatedOrgGrp (15 entries)
| Transaction TypeTransactionTypeTxt | InvolvedInvolvedAmt | Method Of Amount DeterminationMethodOfAmountDeterminationTxt |
|---|---|---|
| SCHEPENS EYE RESEARCH INSTITUTE INC | ||
| B | $1,216,859 | CASH |
| SCHEPENS EYE RESEARCH INSTITUTE INC | ||
| C | $201,997 | CASH |
| SCHEPENS EYE RESEARCH INSTITUTE INC | ||
| P | $1,247,274 | CASH |
| SCHEPENS EYE RESEARCH INSTITUTE INC | ||
| Q | $841,786 | CASH |
| CIRCLE COMPANY INC | ||
| O | $123,842 | CASH |
| CIRCLE COMPANY INC | ||
| Q | $162,500 | CASH |
| EMBANKMENT SERVICES INC | ||
| Q | $1,155,000 | CASH |
| EMBANKMENT SERVICES INC | ||
| O | $1,376,520 | CASH |
| SCHEPENS EYE RESEARCH INSTITUTE INC | ||
| B | $841,628 | CASH |
| MASS EYE & EAR PENSION PLAN | ||
| R | $8,637,931 | CASH |
| MASS EYE & EAR ASSOCIATES | ||
| Q | $29,853,316 | CASH |
| MASS EYE & EAR ASSOCIATES | ||
| B | $4,526,953 | CASH |
| MASS EYE & EAR ASSOCIATES | ||
| C | $423,233 | CASH |
| MASS EYE & EAR ASSOCIATES | ||
| O | $9,372,368 | CASH |
| MASS EYE & EAR ASSOCIATES | ||
| R | $7,720,720 | CASH |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | SCHEDULE R, PART V, LINE 15: | FormAndLineReferenceDesc |
| Explanation | CONTRIBUTIONS REPRESENT AMOUNTS CONTRIBUTED BY THE INFIRMARY FOR EMPLOYEE RETIREMENT BENEFITS AS REQUIRED BY THE PENSION PLAN'S FUNDING POLICY. | ExplanationTxt |